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Abstract
There are over 15.5 million cancer survivors in the U.S. currently, increasing to over 20
million by 2026. Long-term cancer survival has raised awareness for the issues that affect quality
of life (QoL) after treatment. Fatigue and subjective cognitive dysfunction are common quality
of life concerns for survivors but little is known regarding prevalence of these problems in daily
life. The purpose of the current project is to examine these concerns after treatment using data
from a 2 week daily diary study of breast cancer survivors up to 3 years post-treatment. Of
importance is determining the factors that contribute to reporting decreased QoL.
Taken together, our findings suggest that within-persons, survivors who reported worse
mood and physical function tended to also report higher levels of fatigue. Similarly, subjective
reporting of cognitive function is influenced by current mood and physical symptoms such as
fatigue. Demographic characteristics and depressive symptoms prior to the study were unrelated
to fatigue and subjective cognitive function. This dissertation advances the current understanding
of daily QoL issues. These findings also highlight the importance of capturing these experiences
in daily life.
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Chapter One: Introduction
The number of cancer survivors in the United States is expected to increase from 15.5
million in 2016 to 26.1 million by 2040 (Bluethmann, Mariotto, & Rowland, 2016). Due to the
increasing numbers of survivors the American Cancer Society (ACS) has placed greater
emphasis on research to help improve quality of life (QoL) after treatment (American Cancer
Society, 2015). Key QoL outcomes identified include: fatigue, cognitive impairments, pain,
depression, and sleep disturbance. These post-treatment outcomes have received much attention
(Bower et al., 2011; Boykoff, Moieni, & Subramanian, 2009). Guidelines have been developed
to improve QoL for long-term survivors and elucidate areas for future research (Denlinger et al.,
2014; Runowicz et al., 2015). The goal is to alleviate, and in the future prevent, these issues
(American Cancer Society, 2015) by raising awareness of the survivorship experience and
identifying it as a public health concern including the development of care plans to deliver
quality care (Hewitt, Greenfield, Stovall, & Board, 2006).
Fatigue and subjective cognitive dysfunction are the most commonly reported and may
have the greatest impact on QoL (Bower, 2014; Boykoff et al., 2009). As elaborated below,
fatigue and subjective cognitive function make it challenging for survivors to maintain usual
function during daily life, but are not well-understood. Fatigue is considered a subjective general
tiredness and lack of energy not alleviated by rest and makes it difficult to complete tasks (Curt
et al., 2000; Minton et al., 2013). Identifying survivors with high levels of fatigue or at greater
risk is difficult, but important to improve QoL (Piper & Cella, 2010). Research has identified
demographic and psychological factors associated with fatigue. These factors include age and
1

education (Bower, Ganz, Aziz, & Fahey, 2002) and negative mood (Bower et al., 2000; S. L.
Curran, Beacham, & Andrykowski, 2004). Subjective cognitive impairment is described as
perceived problems in memory, concentration, language, and learning assessed via self-report
and may interfere with daily life or negatively impact QoL (Pullens, De Vries, & Roukema,
2010). Subjective cognitive deficits can impact work and family roles (Boykoff et al., 2009).
Previous research has relied on retrospective self-report measures to examine QoL after
treatment. Less emphasis has been placed on examining these issues in daily life contexts where
they are experienced (Bower, 2014; Bower et al., 2011). Cross-sectional and longitudinal studies
have found that individual differences in negative mood (Poppelreuter et al., 2004; Rey et al.,
2012; Shilling & Jenkins, 2007), fatigue (Ribi et al., 2012), lower levels of education (Rey et al.,
2012) are related to reporting increased cognitive dysfunction among cancer survivors.
Understanding these processes after treatment will help to guide treatment decisions and improve
patient outcomes in the future (Ancoli-Israel et al., 2006). This includes the development and
delivery of interventions to treat modifiable risk factors and viable treatment options for patients
experiencing post-treatment side effects.
A limitation of the existing research is the lack of evidence on which to base guidelines
(Runowicz et al., 2015). Overall, greater emphasis has been placed on QoL after treatment to
understand how these experiences operate in daily life. How these processes are experienced in
daily life has largely been overlooked. The current doctoral dissertation will address the need to
examine daily experiences of QoL issues among breast cancer survivors. This was accomplished
by using data from a daily diary study to determine which daily factors are associated with
fatigue and subjective cognitive function. This research will help to identify survivors that have
heightened fatigue or subjective cognitive dysfunction and make it possible to administer
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treatments to alleviate the symptoms and improve function in daily life. The following chapter
presents a review of what is known about fatigue and cognitive function after cancer treatment.
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Chapter Two: Literature Review
Fatigue and subjective cognitive impairment are two of the most common QoL issues
among survivors. This review will describe these post-treatment outcomes and summarize the
literature on risk factors. Understanding what predicts daily fatigue and subjective cognitive
impairments among cancer survivors is important for identifying individuals with these longterm QoL issues and to target life domains to improve outcomes. Existing knowledge of
commonly reported QoL issues that cancer survivors experience in daily life will be presented.
Lastly, this review will overview current methods of assessing QoL issues post-treatment and
describe the approach taken in the current dissertation.
Cancer Survivors
In 2016 there were over 15.5 million cancer survivors (individuals undergoing treatment
and post-treatment) in the U.S. and just over 3 million are breast cancer survivors (ACS, 2018).
Earlier diagnosis and treatment advances have increased cancer survival rates. Survival rates are
higher among breast cancer survivors (90%) compared to other cancers (60%) surviving 5 years
after diagnosis (ACS, 2018). Breast cancer is also the most common site (41%) among female
cancer survivors (DeSantis et al., 2014). Increased survival rates suggest that a greater emphasis
on life after treatment is needed to address this growing public health concern. Both the cancer
itself and its treatment are thought to contribute to decreased QoL in the months or years after
treatment (Mehnert et al., 2007). As survivors resume work and family roles after treatment, QoL
issues may have the greatest impact. Among breast cancer survivors, those treated with
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chemotherapy may be at greater risk for worse long-term QoL and physical functioning
compared to those that underwent other treatment (Ganz et al., 2002). Fatigue and subjective
cognitive dysfunction are common among breast cancer survivors, although not all survivors are
made aware of the potential long-term QoL issues associated with survivorship (DeSantis et al.,
2014; Minton et al., 2013; Pinto & de Azambuja, 2011).
QoL Outcomes
Fatigue
Fatigue is one of the most frequently reported cancer- and treatment-related side effect
(Bower, 2014; Curt et al., 2000; Fernandes, Stone, Andrews, Morgan, & Sharma, 2006) and the
most important to patients due to the impact on physical and social function (P. C. Stone et al.,
2000). Information about cancer-related fatigue has largely come from cross-sectional studies
(Ancoli-Israel, Moore, & Jones, 2001). These studies compare individuals at a single time point,
typically using a retrospective report. More recent studies have included multiple time points, but
little research has examined fatigue on a daily basis. From this research the definition and
prevalence of fatigue has remained elusive. Broadly, fatigue is considered a perceived experience
of physical, cognitive, and/or emotional tiredness, exhaustion, and weakness with a lack of
energy (Hofman, Ryan, Figueroa-Moseley, Jean-Pierre, & Morrow, 2007; Mock et al., 2000;
Schwartz, 2000). Often fatigue interferes with daily routines and usual function, but is not easily
predictable by recent activity level (Curt et al., 2000; Mock et al., 2000). It is also considered the
most distressing side effect due to the reduction in function for the months and years after
treatment (Hofman et al., 2007; Minton et al., 2013). Persistent fatigue could prevent survivors
from returning to activities that improve health and QoL (Hofman et al., 2007).

5

Depending on the cancer population studied and assessment mode, prevalence estimates
of fatigue vary greatly. Rates of fatigue have been found to be higher among cancer patients (5668%) during treatment compared to healthy controls (20-22%; Fernandes et al., 2006; Goldstein
et al., 2012). These rates are higher among survivors undergoing chemotherapy with up to 80%
having reported fatigue (Hofman et al., 2007). One study found that fatigue is often
underreported by survivors in clinical settings (P. C. Stone et al., 2000). Some patients felt as
though fatigue is an unavoidable and untreatable issue during and after treatment. After treatment
has concluded, approximately 33% to 42% of survivors have experienced fatigue (Goldstein et
al., 2012; Hofman et al., 2007; Minton et al., 2013). Those who received chemotherapy treatment
appear to be at higher risk. One example is that breast cancer survivors treated with
chemotherapy are more susceptible to fatigue even when engaging in similar activities as healthy
controls (S. L. Curran et al., 2004).
The course of fatigue after treatment is difficult to discern. One study found that even 6
years after treatment 1/3 of cancer survivors report fatigue and that it interferes with physical
functioning (Jones et al., 2016). In contrast, another study found that fatigue symptoms improved
over 12.5 years after cancer treatment (Hsu, Ennis, Hood, Graham, & Goodwin, 2013). Although
fatigue is reported for years after treatment, some cross-sectional and longitudinal studies that
examined the association between time since treatment and fatigue find no relationship (Mehnert
et al., 2007; Servaes, Gielissen, Verhagen, & Bleijenberg, 2007). Discrepancies in prevalence
rates and course present both a challenge to the research and an opportunity to identify
individuals at greater risk for impairment.
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Assessment of fatigue
Existing research utilizes various self-report measures which may not yield the same
findings and helps to explain the wide range of fatigue reported after treatment. Commonly used
questionnaire assessments developed for use among cancer survivors include the Functional
Assessment of Cancer Therapy Fatigue (Yellen, Cella, Webster, Blendowski, & Kaplan, 1997)
and the Fatigue Symptom Inventory (FSI; Minton & Stone, 2009). For example, the FSI is a
validated, recommended measure of fatigue administered to cancer survivors after treatment
(Hann et al., 1998). Emphasis is placed on fatigue severity and how much this interferes with
activities, relationships, and life satisfaction experienced over the past week (Hann et al., 1998).
This largely ignores variations that occur across days, but rather rely on survivors’ retrospective
self-assessments of average fatigue intensity and interference. Responses depend on an
individual’s perception and recollection of the experience which is susceptible to bias (P. C.
Stone & Minton, 2008). Past experiences could be under or over reported, or influenced by an
individual’s current state. To better understand fatigue in daily life and reduce bias more frequent
measurement is required.
More recent studies have incorporated daily diary methods to assess fatigue daily, rather
than over the past week. Typically, this is accomplished through the use of brief paper surveys or
an electronic device to administer items (Banthia et al., 2006; S. L. Curran et al., 2004; Schwartz,
2000; Schwartz, Mori, Gao, Nail, & King, 2001). One study comparing traditional questionnaire
and diary methods found a lack of agreeance between fatigue collected once via the FSI and
fatigue collected for seven days during the corresponding week (Banthia et al., 2006). This
suggests that unique experiences are assessed and questionnaires alone are not capturing the
entire experience. Additionally, it presents an opportunity to focus on daily assessments of
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fatigue and factors known to be associated to understand how these relationships operate in daily
life.
Factors associated with fatigue
Multiple causes of fatigue and factors contributing to the symptoms have been identified.
Factors associated with fatigue after treatment include genes related to inflammation,
psychological factors (depression, ability to cope with the cancer diagnosis), level of fatigue
before treatment, sleep disturbance, and level of physical activity (Bower, 2014; P. C. Stone &
Minton, 2008). Although not the primary focus of this dissertation, underlying biological
processes related to cancer and its treatment influence the experience of fatigue. For example,
chemotherapy treatment is thought to increase inflammation and is one potential source of
increased fatigue experienced by survivors (Bower & Lamkin, 2013). Also contributed to
chemotherapy, disruptions of core body temperature commonly experienced by cancer survivors
have been associated with hot flashes contributing to increased fatigue, sleep disruptions,
reduced QoL (Carpenter, Gautam, Freedman, & Andrykowski, 2001). Several other studies have
shown that sleep disturbance, difficulty functioning related to cancer, and tiredness were reported
more frequently among those reporting greater fatigue up to 5 years after treatment (AncoliIsrael et al., 2006; Goldstein et al., 2012). One study suggested that subjective tiredness is related
to these biological processes (Dijk, Duffy, & Czeisler, 1992). Although sleep disturbance is often
related to fatigue, when daily sleep disturbances and duration have been examined to explain
greater levels of fatigue in breast cancer survivors, sleep factors were unrelated to daily reports
of fatigue (S. L. Curran et al., 2004). Underlying biological processes of fatigue and the relation
to psychological factors are still not well understood.
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Influences on fatigue can be categorized as psychological factors, physical factors, and
demographic characteristics. A substantial body of research has endorses a relationship between
negative mood states (e.g., depressive symptoms, anxiety) and fatigue among cancer survivors.
Among female cancer patients undergoing treatment those with higher rates of depression and
lower QoL have been associated with fatigue (Fernandes et al., 2006). Breast cancer survivors
with worse mood, greater anxiety and depression, reported increased fatigue when assessed with
common retrospective fatigue measures (Bower et al., 2000; Carpenter et al., 2001; Curt et al.,
2000; Jones et al., 2016) and assessed monthly for two years after treatment (Servaes et al.,
2007).
The studies above showed links between fatigue and mood in terms of individual
differences: survivors who report worse mood relative to other survivors. There may also be
links between fatigue and negative mood that unfold within individuals in real time. That is, to
what extent is a survivors fatigue higher when she is in a negative mood compared to her fatigue
on a when she is not in a negative mood. There is evidence to suggest that when assessed over
the course of 5 days, daily negative mood and fatigue are associated (S. L. Curran et al., 2004).
An inverse relationship was found, greater fatigue was experienced on days when less positive
mood was reported. Several explanations of this relationship have been proposed. One
explanation is that worse mood and the distress experienced from increased fatigue are related.
This finding suggests that although negative mood influences fatigue, it is only one component.
A second explanation is that the relationship is reciprocal. Worse mood and inactivity lead to
increased fatigue, due in part to the relationship between decreased physical functioning and
fatigue following treatment (Mehnert et al., 2007). However, when examined daily, fatigue can
be present when no negative psychosocial experiences are reported (S. L. Curran et al., 2004).
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Associations between self-reported physical factors, activity, and fatigue are well
established. Broadly, cross-sectional and longitudinal studies examining the relationship between
physical function and fatigue find that survivors who are more functionally limited tend to
experience worse fatigue (Jones et al., 2016; Servaes et al., 2007). Individual differences in longterm fatigue have been attributed to pain and activity. Survivors who report more pain tended to
also report higher levels of fatigue (S. L. Curran et al., 2004; M. E. Schmidt et al., 2015).
Similarly, breast cancer survivors who report reduced activity also report higher levels of fatigue
(S. L. Curran et al., 2004; M. E. Schmidt et al., 2015). Most studies focusing on the relationship
between fatigue and physical activity have been intervention studies; however there is only mild
support for a connection. There is stronger support for the efficacy of psychological interventions
(Jacobsen, Donovan, Vadaparampil, & Small, 2007). Some studies have found that fatigue
symptoms are alleviated with increased physical activity (Jacobsen et al., 2007; Minton et al.,
2013; Mormont et al., 2000). One study examining the efficacy of an exercise program found
that daily reported fatigue was lessened and function increased among breast cancer survivors
(Schwartz, 2000). Engaging in appropriate activities for an individual may improve health and
QoL. The ACS recommends at least 150 minutes of exercise per week for cancer survivors
(Rock et al., 2012). However, intensity of the activity should be considered rather than activity
alone (S. L. Curran et al., 2004). Over activity throughout the day could lead to increased fatigue.
A study examining daily activity patterns of cancer survivors found greater morning activity lead
to higher levels of fatigue later in the day (Timmerman, Weering, Tönis, Hermens, &
Vollenbroek-Hutten, 2015).
Demographic characteristics have been associated with reporting increased fatigue
among breast cancer survivors. Younger age (Bower et al., 2002; Schwartz, 2000) and being
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unmarried (Bower et al., 2002; Jones et al., 2016) has been associated with increased fatigue.
One explanation is that less social support is related with increased fatigue. However, the role of
social support has not been extensively examined in the literature (Servaes, Verhagen, &
Bleijenberg, 2002). Employment-related factors, such as level of education and income among
breast cancer survivors have been associated with fatigue. Fatigue is higher among survivors
with lower educational attainment (Bower et al., 2002; M. E. Schmidt et al., 2015) and lower
income (Bower et al., 2002; Jones et al., 2016). After treatment has concluded, decreased
function often experienced by survivors with fatigue could impact work activities and earning
capacity (Minton et al., 2013). Additionally, increased fatigue has been related to change in
employment status or type (Curt et al., 2000). Taken together, fewer social and financial
resources contribute to increased fatigue.
Cognitive Function
Cognitive declines have been documented in numerous domains and across cancers
(Small, Scott, Jim, & Jacobsen, 2015; Wefel, Kesler, Noll, & Schagen, 2015). Subjective
declines in attention, memory, language, and concentration are the most frequently reported
problems (Ahles, Root, & Ryan, 2012; Mehnert et al., 2007). Additionally, studies have reported
objectively assessed impairments in two or more cognitive domains after chemotherapy
treatment (Jim et al., 2009; Poppelreuter et al., 2004). This can include general cognitive
function, attention, executive function, working memory, processing speed, verbal memory, and
visual memory (Ahles et al., 2012; Collins, MacKenzie, Tasca, Scherling, & Smith, 2013; Jim et
al., 2012; Kreukels, van Dam, Ridderinkhof, Boogerd, & Schagen, 2008; Ono et al., 2015).
These impairments are found when compared to healthy controls and survivors who received
other treatments for cancer (Donovan et al., 2005; Jim et al., 2009; K. M. Phillips et al., 2012).
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Slower reaction time and processing speed have even been associated with self-reported history
of cancer and chemotherapy among older adults (Anstey, Sargent-Cox, Cherbuin, & Sachdev,
2015). Another study found that although all treatment groups improved in processing speed, the
chemotherapy group reported more subjective cognitive dysfunction (Ahles et al., 2010).
Regardless of the improvements in objective function, cognitive complaints remained. Attention
has been identified as the most affected and subjective reports revealed that attention difficulties
were reported by 22% of survivors (Poppelreuter et al., 2004).
There is considerable variation in the definition and assessment of self-reported cognitive
function and impairments. Subjective cognitive impairment is a broad label that often subsumes
other terms used to describe similar constructs (Hill, Mogle, Munoz, Wion, & Colancecco,
2015). In a recent review, Pullens et al. (2010) defined subjective cognitive impairment as
deficits in attention, memory, language, and learning that are experienced in everyday life by an
individual. Among cancer survivors these impairments are often collectively termed
‘chemobrain’ and described as frustrating and upsetting, and in more severe cases decreased
independence occurred (Boykoff et al., 2009). These experiences are perceived and may not
translate to objective impairment assessed with neuropsychological tests.
Further, those who experience cognitive declines have more difficulties in daily life posttreatment compared to those that remain stable (Wefel et al., 2015). Impairments in executive
functioning are associated with reduced social functioning and involvement, and occupational
complications (Wefel et al., 2015). This can include decreased job performance and efficiency as
survivors transition back into daily life (Boykoff et al., 2009). One study found that over the two
years post-treatment, subjective memory and attention problems increased from 21% to 42% of
the survivors, which could be attributed to survivors transitioning back to activities of daily life
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(Rey et al., 2012). Findings highlight the importance of examining these problems at beyond the
first few years after treatment.
Subjective and objective cognition
Research has largely focused on the relationship between subjective and objective
cognitive function post-treatment with the assumption that individuals who report worse
subjective cognitive function tend to also score worse on assessments of objective function.
However, the relationship is mixed at best and research suggests that the constructs are separate
(Hulur, Hertzog, Pearman, & Gerstorf, 2015; Sunderland, Harris, & Baddeley, 1983). Subjective
cognitive dysfunction is more common than objective cognitive impairment among cancer
survivors (Hutchinson, Hosking, Kichenadasse, Mattiske, & Wilson, 2012). Up to 70%
subjectively report memory loss and difficulty concentrating (Boykoff et al., 2009), whereas only
15-25% exhibit impairment in objective performance based on normative criteria (Boykoff et al.,
2009; Wefel et al., 2004). Survivors may experience objective decline, but it remains undetected
by neuropsychological test batteries and the norms used to determine impairment (Wefel et al.,
2015). Most studies find little to no association and only a third of studies find any association
(Hutchinson et al., 2012; Mehnert et al., 2007; Poppelreuter et al., 2004). Recent meta-analyses
have found small effect sizes (0.06 and 0.15) in the relationship between objective and subjective
cognitive function (Beaudoin & Desrichard, 2011; Crumley, Stetler, & Horhota, 2014).
Several explanations have been proposed for the discrepancy between the subjective
reports of cognitive difficulties and impairment defined by objective criteria. One explanation for
the lack of association is the issue of reference periods (Poppelreuter et al., 2004). Objective
function is typically measured at one time point and compared to norms used for clinical
diagnosis or a threshold for cognitive impairment, rather than comparing to an individual’s
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previous level of function. Subjective function is recollection-based and involves an appraisal of
current function and past function which is susceptible to bias during longer recall periods
(Cavanaugh, Feldman, & Hertzog, 1998; Poppelreuter et al., 2004). In sum, objective cognitive
assessments and subjective function reports may not overlap in the periods that they are
assessing.
Other explanations have also been proposed. A second explanation is that anxiety and
depression has been found to explain the relationship between subjective impairments and
cognitive performance (Poppelreuter et al., 2004). Evidence suggests that current mood may
influence reporting of subjective impairments and objective performance. For example,
depressive symptoms have been associated with increased subjective cognitive dysfunction
among breast cancer survivors (Janelsins et al., 2017). Anxiety and depression may have a
greater impact in daily life rather than on objective measures of function and may explain the
relatively consistent relationship with subjective cognitive function. Finally, age-related changes,
underlying biological processes, and the type of comparison group may elucidate the differences
between subjective and objective cognitive performance (Beaudoin & Desrichard, 2011;
Cavanaugh et al., 1998; Crumley et al., 2014; Gunstad et al., 2006).
Subjective cognitive impairment may have a greater impact on daily function than
objective impairment (Shilling & Jenkins, 2007) and is one of the most commonly reported side
effects of treatment (Boykoff et al., 2009). Six months after chemotherapy treatment 37% of
breast cancer survivors reported subjective cognitive decline compared to pre-treatment reports
(Janelsins et al., 2017). Lower QoL among those who reported subjective cognitive problems
indicated that perceived problems impact daily life during the 2 years following breast cancer
treatment (Rey et al., 2012). This indicates a long-term QoL issue that is disruptive to daily life.

14

Previous research among older adults has indicated that greater experiences of subjective
impairment and memory lapses are related to subjective psychological factors such as anxiety,
depression, and activity (Rey et al., 2012; Ribi et al., 2012; Shilling & Jenkins, 2007). At the
individual difference level, survivors who report worse negative mood tend to also rate
subjective cognitive function as worse. Self-reported cognitive dysfunction was associated with
health-related QoL but the link between objective cognitive impairment and the subjectively
reported experiences is less clear (e.g. cognitive complaints, fatigue, and health-related QoL;
Mehnert et al., 2007). In sum, the subjective experience of survivorship appears to be different
from objective measurements of cognition and there is a more consistent relationship among
self-reported cognition and other QoL factors exists.
Assessment of subjective cognitive function
Beliefs about cognition and memory may influence subjective ratings (Cavanaugh et al.,
1998). Typically, one does not assess memory unless prompted, responses are often mood- and
thought-based with question wording potentially influencing the answer (Cavanaugh et al.,
1998). Most adults have difficulty accurately assessing memory and cognitive function (Crumley
et al., 2014; Pearman, Hertzog, & Gerstorf, 2014; Sunderland et al., 1983). Assessments of
subjective cognitive function range from interview questions focused on one domain (typically
memory) to standard questionnaires (Pullens et al., 2010). Self-report measures that utilize Likert
(or similar) scales with a recent past timeframe (i.e., over the past week) are most commonly
used to assess subjective cognitive function (Rabin et al., 2015). The Functional Assessment of
Cancer Treatment Cognitive is a validated questionnaire administered to cancer survivors
(FACT-Cog; Cella et al., 1993). Questions focus on subjective cognitive impairments, abilities,
QoL, and comments from others over the past seven days. Whether knowing that subjective
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cognitive dysfunction is a side effect of treatment, or priming, has been proposed as a potential
source of increased reporting of problems among cancer survivors. After participants were
primed with information on cognitive issues experienced post-treatment, those who received
chemotherapy reported more problems on a subjective cognitive function questionnaire
(Schagen, Das, & Vermeulen, 2012). However, general knowledge of cognitive issues did not
influence reported problems suggesting that priming alone does not explain the prevalence of
subjective cognitive dysfunction (Schagen et al., 2012).
More recently, subjective cognition has been assessed with questions concerning daily
memory lapses administered via smartphones among healthy adults (Mogle, 2011; Mogle,
Munoz, Hill, Smyth, & Sliwinski, 2017). Although this method captures daily subjective
cognition in the environment that it is experienced, the focus is primarily on memory. It is
difficult to discern the prevalence of subjective cognitive dysfunction and what puts some
survivors at greater risk when measures tend to focus primarily on memory. A recent review of
studies that examined subjective cognitive impairment among breast cancer survivors found that
less than half of the included studies reported prevalence and were inconsistent ranging from
21% to 90% (Pullens et al., 2010). This indicates that this is a relatively understudied issue
despite the daily QoL implications.
Factors associated with subjective cognitive function
The potential causes and factors associated with cognitive dysfunction among aging
adults and cancer survivors have long been a focus of research. Similar to mechanisms that may
underlie fatigue, the biology of cancer and inflammation impair cognition (Ahles & Saykin,
2007). Shared risk factors and biological mechanisms place a subset of cancer patients at higher
risk for objectively measured cognitive changes including older age, genes, and less cognitive
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reserve (Ahles et al., 2012; Ahles & Saykin, 2007; Bower, 2014; Mandelblatt et al., 2013; Ono et
al., 2015; Small et al., 2015; Wefel et al., 2015). Subjective cognitive complaints and objective
cognitive performance have also been shown to be related to structural changes in the brain
assessed via neuroimaging (Wefel et al., 2015). These problems are bothersome enough to
disrupt daily function and this becomes particularly important as survivors transition back to
regular responsibilities post-treatment.
Previous research has further identified chemotherapy treatment, psychological factors (e.
g., depressive symptoms), and demographic characteristics (e.g., education and employment)
related to subjective cognitive dysfunction (Rey et al., 2012). Chemotherapy is increasingly used
to treat cancer and its potential role in cognitive function has been investigated both crosssectionally and longitudinally (Ahles et al., 2012; Wefel, Saleeba, Buzdar, & Meyers, 2010;
Wefel, Vardy, Ahles, & Schagen, 2011). When compared to other cancer treatment groups over
time, survivors who received chemotherapy reported greater changes in subjective memory and
concentration and a third reported that the changes were noticeable to others one year after
treatment (Shilling & Jenkins, 2007). Potential sources of the chemotherapy effect have been
proposed. One explanation posits that increased inflammation after treatment which contributes
to DNA damage and continues the inflammatory response (Ahles & Saykin, 2007). Another
explanation is that small amounts of chemotherapy cross the blood-brain barrier and damage
cells (Ahles et al., 2012; Ahles & Saykin, 2007).
Psychological characteristics relating to mood and tiredness have also been found to
impact subjective cognitive function. Individual differences in negative affect (e.g., anxiety and
depression), sleep disturbances, fatigue, and QoL issues have been associated with subjective
complaints of memory and concentration (Pullens et al., 2010; Shilling & Jenkins, 2007). Studies
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utilizing retrospective questionnaire measures have reported consistent findings betweenpersons. Findings suggest a connection between negative mood and survivors reporting worse
subjective cognitive function (Klemp et al., 2018; Poppelreuter et al., 2004; Von Ah & Tallman,
2015). Other studies have found that depressive symptoms at one year (Shilling & Jenkins, 2007)
and up to 2 years (Rey et al., 2012) after treatment were associated with reporting more
subjective cognitive dysfunction. One explanation for the connection is that depressive
symptoms and anxiety may heighten awareness of memory problems or increase the negative
impact of perceived problems leading to increased reporting.
Some studies have found that individual differences in tiredness and fatigue are
associated with subjective cognitive function. Among breast cancer survivors one year after
treatment tiredness was associated with subjective cognitive function (Ribi et al., 2012).
Similarly, two years after treatment alertness and tiredness are related to cognitive function (Rey
et al., 2012). Among studies examining individual differences in fatigue and subjective cognitive
function, reporting higher levels of fatigue is associated with worse subjective cognitive function
(Klemp et al., 2018; Myers, Wick, & Klemp, 2015; Von Ah & Tallman, 2015). Taken together
increased levels of fatigue and tiredness negatively impact ratings of subjective cognitive
function in the years after treatment. Another study found that fatigue and subjective cognitive
function were not related; however, cognitive complaints were more common among those with
fatigue (Mehnert et al., 2007). Subjective tiredness and alertness are thought to underlie
cognitive function and help to explain the relationship between fatigue subjective cognitive
function (Dijk et al., 1992).
Demographic characteristics such as education, age, and memory aids have been
proposed as possible explanations in both the aging and cancer survivorship literature. Previous
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research on cognitive function after treatment has focused on objective assessments which has
led to less knowledge about subjective cognitive function and demographic factors. Studies of
aging have consistently found that individuals with more education also rate subjective memory
as better (Hulur, Hertzog, Pearman, Ram, & Gerstorf, 2014; Hulur et al., 2015). A recent metaanalysis found that higher levels of education are associated with better assessment of memory
and cognitive function among older adults (Crumley et al., 2014). Among breast cancer survivors
the relationship between education and subjective cognitive function is mixed. One crosssectional study found that five years after treatment for breast cancer there was no association
between educational attainment and subjective cognitive function (Mehnert et al., 2007). Across
a two year study following treatment education and employment were both associated with
reporting more subjective cognitive problems (Rey et al., 2012). Consistent with this research
another longitudinal study found that survivors not only had lower cognitive function and worse
financial standing compared to healthy controls, but cognitive function did not improve 12 years
after treatment (Hsu et al., 2013).
The association between subjective cognitive function and age is mixed. Among breast
cancer survivors, younger survivors report worse subjective cognitive function than older
survivors (Janelsins et al., 2017; Myers et al., 2015). Longitudinal studies in the aging literature
highlight the inconsistent relationship. One study found that older participants tend to rate their
memory as better than younger participants (Hulur et al., 2014). In contrast, another study found
that older age was associated with worse subjective memory (Hulur et al., 2015). Tools to
improve memory function, such as lists or reminder notes may explain better ratings of
subjective cognitive function in later life. Memory aids are a potential coping strategy that are
easy to employ in daily life. However, when the influence of memory aid usage on subjective
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memory was examined among older adults, evidence did not support a relationship (Parisi et al.,
2011).
Function in Daily Life
Traditionally, studies have examined fatigue and subjective cognitive function from
cross-sectional or longitudinal designs with time points ranging from months to years. Daily
behavior and experiences are collected via questionnaire in a different environment than they
naturally occur, such as a laboratory setting (Shiffman, Stone, & Hufford, 2008). Furthermore,
assessment often takes the form of retrospective reporting about experiences that happened
during the prior week or beyond (Shiffman et al., 2008). A different approach is the use of
intensive periods of study such as ecological momentary assessment (EMA) and daily diary
methods. These are applicable in a broad range of research (Moskowitz & Young, 2006).
However, Fahrenberg, Myrtek, Pawlik, and Perrez (2007) argue that EMA is still used far less in
psychology, despite the increasing evidence that questionnaires are poorly suited to capture
situations that occur in daily life. Further, questionnaires are often inferior to EMA methods, yet
continue to be widely used (Fahrenberg et al., 2007; Moskowitz & Young, 2006). Recall bias
(Runyan & Steinke, 2015) and ambiguous time frames prevent questionnaires from capturing
daily events accurately, rather it is a representation (Fahrenberg et al., 2007).
Multiple assessments of behavior and experiences can be collected in real-time and in
natural settings with EMA and diary methods (Runyan & Steinke, 2015; Shiffman et al., 2008).
Assessments can be completed throughout the day or once per day. Two primary advantages of
diary studies are increased ecological validity and reduced retrospective bias (Bolger, Davis, &
Rafaeli, 2003; Moskowitz, Russell, Sadikaj, & Sutton, 2009; Shiffman et al., 2008). Ecological
validity is improved when experiences are assessed in natural settings compared to a clinical or
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laboratory setting. Retrospective bias is reduced due to a shorter recall time compared to
traditional questionnaires. Relationships can then be examined over shorter periods of time
(Heron & Smyth, 2010). For example, variation in daily fatigue can be observed across days and
factors that are associated with reporting increased fatigue. Comparisons across survivors and
variations within survivors from day-to-day are possible. For example, it is possible to compare
survivors who are higher in negative affect to survivors lower in negative affect in general, and
how negative affect may vary within each survivor across days.
Several benefits and drawbacks of collecting data in daily life exist. First, technology
(e.g., smartphones and tablets) is increasingly used in daily diary research (Runyan & Steinke,
2015; Trull & Ebner-Priemer, 2013). The prevalence of smartphone use translates to familiarity
for participants and a non-invasive, practical tool for researchers (Miller, 2012; Runyan et al.,
2013; Runyan & Steinke, 2015). Unfamiliar laboratory or clinical settings may influence
reporting of fatigue and subjective cognitive function thus natural settings are ideal to measure
experiences. Further, questionnaires administered at one time point fail to capture variability in
experiences (Runyan & Steinke, 2015) and are susceptible to potential ‘good’ or ‘bad’
measurement days in which a participant is not having a typical week. Multiple assessments over
shorter intervals are needed to capture a more reliable measure and understand how processes
operate in daily life. Compared to traditional research designs however, daily diary studies
require a greater investment from the participant (Bolger et al., 2003). Burden and compliance
could impact reliability (Moskowitz et al., 2009). Therefore, the number of assessments should
be carefully considered. The lack of experimental control in daily life is another potential
drawback of diary studies and limits the ability to determine cause and effect, but time-ordered
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relationships can be examined (Fahrenberg et al., 2007). Nevertheless, to understand how
processes operate in daily life natural settings are most appropriate.
In addition, both specific and average measures are calculated (Moskowitz et al., 2009).
Specific measures obtained through assessing behavior at multiple time points, across situations
in order to observe variability in behavior based on context (Bolger et al., 2003; Moskowitz et
al., 2009; Shiffman et al., 2008). Previous research has demonstrated that subjective ratings can
fluctuate throughout the day and across days (C. Schmidt, Collette, Cajochen, & Peigneux, 2007;
Valdez, Ramirez, & Garcia, 2012). Repeated sampling is necessary to assess these effects and to
account for intraindividual variation in responses (Blatter & Cajochen, 2007; Mansell, 1985).
These are changes that occur within-person, from day-to-day. If ratings are collected only at one
time point (i.e., retrospective questionnaires) variation across settings (i.e., EMA and dairy
methods) is not captured. The ability to find consistent associations is likely due to the time
frames in which a construct is measured.
Sampling behavior across days also provides a more accurate estimate (Mansell, 1985)
and improves validity (Sliwinski, 2008). Average measures can be obtained by aggregating
across assessments (i.e., person-averages) or the entire day to provide a summary measure
(Bolger et al., 2003) and are able to provide a more reliable estimate by averaging across
multiple observations rather than relying on a single observation (Mansell, 1985).
Between and Within Persons Comparisons
Within-person processes are of interest in most psychological studies, yet many only
collect data between-person (P. J. Curran & Bauer, 2011). For example, whether survivors who
report higher depression experience worse self-reported cognitive function could be examined
using between or within-person comparisons. Between-persons comparisons identify
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characteristics that differ across individuals (e.g., age, education) and contribute to differences in
an outcome, and on the other hand within-person comparisons examine characteristics that differ
within an individual. In other words, an individual is compared to themselves, rather than others.
Cross-sectional studies are not able to provide within-person comparisons as previously
mentioned. Typical behavior may not be accurately represented, but rather one individual on a
good day and another on a bad day. This ignores the within-person variability, how people are
changing from day-to-day. In order to better understand the daily impact of cancer survivorship
and associated factors, research will need to focus on studying this in daily life and across
multiple days.
Within persons comparisons examine the variability associated with an individual’s
responses on multiple occasions. For example, we can examine how a survivor’s fatigue is
higher or lower relative to her own average and then identify predictors of this variation. Daily
diary methods are able to collect longitudinal data (multiple measures over multiple moments)
and to identify peak experiences, when reports are highest across days. This within-person
variability and the factors that contribute to greater daily fatigue or subjective cognitive function
can be examined rather than only between-person differences. This is an advantage of
longitudinal designs, EMA and diary studies. Advanced statistical methods, such as multilevel
modeling (MLM) are also required to distinguish differences (and what predicts these) in
survivors on average and fluctuations within survivors across days (P. J. Curran & Bauer, 2011;
Hoffman & Stawski, 2009).
Current Study
The purpose of the current study was to determine the factors that impact daily reported
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of fatigue and subjective cognitive function. Using daily diaries it is possible to determine which
patients are at the highest risk for decreased QoL and on what days (Wefel et al., 2015).
Aim 1 described between person differences and within person variation in daily fatigue
collected at the end of each day. Within person (day-level) predictors (e.g., mood, pain, and
activity from daily diary surveys) and between person (person-level) predictors (e.g., personaverages of day-level predictors, age, income, time since treatment, retrospective fatigue,
depressive symptoms) on ratings of daily fatigue collected at the end of the day were examined.
Research questions of interest for the first Aim included: 1) Does daily reported fatigue differ
across days (within-person variation) and across individuals (between- person differences)? 2)
Are daily diary measures, such as mood and physical activity related to daily fatigue? Are these
predictors able to account for variation across days and individuals? 3) Are traditional in-person
measures related to daily fatigue? Specifically, what are the relationships between daily fatigue
and demographic and clinical characteristics, and retrospective measures of fatigue and
depressive symptoms?
Aim 2 described between person differences and within person variation in daily
subjective cognitive functioning (thinking as fast as usual, memory as good as usual, and mind as
sharp as usual) collected at the end of the day. Within person (day-level) predictors (e.g., ratings
of mood, fatigue, and memory lapses from daily diary surveys) and between person (personlevel) predictors (e.g., person means of day-level predictors, age, education, time since treatment,
retrospective subjective cognitive function, depressive symptoms) on ratings of daily subjective
cognitive performance collected at the end of the day were examined. Important questions for
Aim 2 included: 1) Does daily reported subjective cognitive function differ across days (withinperson variation) and across individuals (between-person differences)? 2) Are daily diary
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measures, such as mood and memory lapses related to daily subjective cognitive function? Are
these predictors able to account for variation across days and individuals? 3) Are traditional inperson measures related to daily subjective cognitive function? Specifically, what are the
relationships between daily subjective cognitive function and demographic and clinical
characteristics, and retrospective measures of subjective cognitive function and depressive
symptoms?
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Chapter Three: Methods
Participants
Data from the larger Daily Cognitive Function among Breast Cancer Survivors study (H.
Lee Moffitt Cancer Center’s American Cancer Society Institutional Research Grant 93-032-16;
National Cancer Institute Grant R03 CA191712) was used for the current analyses. The study
utilized daily diary subjective surveys completed at the end of the day and ecological momentary
assessment (EMA) ambulatory cognitive assessments and subjective surveys as well as
questionnaires. The study was approved by the IRB at the University of South Florida and the H.
Lee Moffitt Scientific Review Committee.
Eligible participants were recruited from Moffitt Cancer Center and were 6-36 months
post-chemotherapy for stage II or lower breast cancer, are female, have no cancer recurrence,
and were 40-65 years of age. Medical records were reviewed by trained study coordinators;
eligible participants were sent an invitation letter with an option to opt out of the study before a
research team member contacted by phone. Participants that did not opt out were contacted and
screened for interest and eligibility (age, no vision or hand movement issues which could
interfere with ability to follow study protocol). Eligible participants were also recruited from the
breast clinic where survivors attend post-treatment follow-up visits. For individuals recruited
from the clinic, participants were approached and screened in-person before or after their followup appointment. A separate visit to the research offices for data collection and training was then
scheduled. Figure 3.1 displays participant recruitment and enrollment.
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During an in-person visit to the research offices participants signed informed consent and
completed a standard neuropsychological test battery administered by a trained research assistant
assessing memory, processing speed, executive function, and attention. Testing was completed in
35 to 45 minutes. Next, participants completed self-report questionnaires assessing depressive
symptoms, cancer-related fatigue, subjective cognitive function, mood and thoughts, activity,
and demographics. The questionnaire packet took approximately 20 minutes to complete.
Participants were then trained to use a study provided smartphone to answer survey questions
and cognitive tasks that were completed for 14 days beginning the next day. Participants were
exposed to all possible question branches and completed an additional survey independently to
ensure that the procedures were understood. Instructions for contacting study staff in the event of
any questions or problems while at home with the study phones were provided. The phone
training typically took 45 minutes.
As part of the 14 day smartphone data collection, participants completed beeped and
daily diary surveys each day. Beeped surveys were prompted quasi-randomly by the phone 5
times per day. Prompts occurred every 2-3 hours and participants were instructed to complete the
survey as close to the prompt as possible. During the smartphone training session, participants
provided their typical wake times. Beep prompts occurred following study schedules that were
assigned based on participants’ self-reported wake time. Beeped surveys collected momentary
self-reported context, experiences, mood, alertness, fatigue, and activity. Following each beeped
survey three brief cognitive tasks were completed to assess attention, working memory, and
perceptual speed, respectively. Beeped surveys and cognitive tasks were typically completed in
approximately 3 minutes.
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Daily diary surveys were self-initiated each night prior to bedtime. The phone did not
prompt the participant to complete the survey. Questions were similar to the beeped survey and
were concerned with the entire day as a whole. This dissertation focuses on participants’ reports
of daily fatigue and daily subjective cognitive function – assessments of memory, thinking, and
mental sharpness. In addition, participants rated questions on each day’s memory lapses (type of
information forgotten), memory aids, mood, physical symptoms, and physical activity. Diary
surveys were completed in approximately 2 minutes.
To ensure that the smartphone was functioning properly and to answer any additional
questions about the surveys participants were contacted on the 1st day and halfway through the
study. Compliance was checked prior to the phone calls to confirm that survey data was stored
on the secure server and to remind participants to keep the smartphone with them throughout the
day. Additionally, at the end of the 14 day study period (day 15) participants were contacted to
provide detailed instructions for powering the phone down and mailing all materials back the
research offices via a prepaid postage mailer. Upon receipt of the smartphone, compliance was
confirmed by downloading all data from the phone. Participants received up to $110 for
completing the study. Incentives were provided to those completing 80% or more of the
smartphone surveys. For a schematic of the study protocol see Figure 3.2.
Predetermined guidelines were followed to establish compliance and rules for excluding
daily diary observations. First, surveys completed outside of the two week study period were
excluded. This included surveys launched on the training day before the 14 day study period
began (day of the in-person visit) or after the study period ended (day 15 or after). Next,
incomplete and duplicate surveys were examined. Surveys were considered incomplete if less
than half of the items were answered and were excluded. Duplicates were defined as more than
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one daily diary survey completed on the same day. For example, daily diary surveys were
excluded if completed in place of a beeped survey. This was determined if a diary survey was
completed in place of any beeped survey during the day, which likely indicated that the
participant accidently launched an diary survey rather than a beeped when she received the
prompt. When two were completed at the end of the day, the first survey was excluded to ensure
that the survey reflected to entire day’s experiences. Lastly, diary surveys completed after 4 AM
(e.g., the cutoff selected for participants with late bedtimes) were excluded.
Measures
The following are variables from in-person measures (person-level) and diary surveys
(day-level) used in the current study (see Figure 3.3).
In-person Measures
Responses on the retrospective fatigue, subjective cognitive function, and depressive
symptoms measures correspond to the week prior to the 14 day smartphone portion of the study.
Demographic and clinical characteristics
Demographic and clinical characteristics were used to describe the sample. Age,
ethnicity, race, education, income, marital status, and work status were all collected using a
demographics questionnaire during the in-person visit. Age and years of education were treated
as continuous variables in analyses. Clinical characteristics, such as time since treatment was
collected via medical record review, were included as covariates.
Fatigue
The Fatigue Symptom Inventory (FSI) is a 14 item questionnaire that was administered
as part of a larger packet of measures during the in-person visit (Hann et al., 1998). The severity
subscale was utilized from this measure which is a sum of 4 items that asked participants to rate
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levels of most, least, and average fatigue over the past week, as well as current level fatigue.
Responses for items ranged from 0 not at all fatigued to 10 as fatigued as I could be on an 11
point scale and scores can range from 0-40. The interference subscale is a sum of 7 items that
asked participants to rate, in the past week, how much fatigue interfered with general activities,
self-care, work, concentration, relationships, enjoyment of life, and mood. Responses for items
ranged from 0 no interference to 10 extreme interference on an 11 point scale and scores can
range from 0-70. Frequency of fatigue was one item that assessed how many days of the week
that fatigue was experienced from 0-7 days. The intensity subscale was included in analyses and
Cronbach’s alpha for this sample was 0.91.
Subjective cognitive function
The Functional Assessment of Cancer Therapy-Cognition (FACT-Cog) is a 37 item
questionnaire that assesses retrospective cognitive function over the past seven days (Chelune,
Heaton, & Lehman, 1986). Item responses ranged from never to several times a day on a five
point scale. All negatively worded items were reverse scored. Items assessed four subscales
perceived cognitive impairments (range: 0-80), quality of life (range: 0-16), comments from
others (range: 0-16), and perceived cognitive abilities (range: 0-36). A total score was calculated
by taking the sum of all 37 items and can range from 0-148. Total score was used in analyses and
Cronbach’s alpha for this sample was 0.97.
Depressive symptoms
The Center for Epidemiologic Studies-Depression scale is a 20 item questionnaire that
assesses depressive symptoms over the past week (Radloff, 1977). Item responses ranged from
1-4 and were rarely or none of the time (less than 1 day), some or a little of the time (1-2 days),
occasionally or a moderate amount of the time (3-4 days), or most or all of the time (5-7 days).
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All positively worded items were reverse scored. A total score was calculated by taking the sum
of all items and can range from 0-60. Cronbach’s alpha for this sample was 0.87.
Daily Diary Surveys
For all daily ratings completed before bed, participants were instructed to consider the
entire day as a whole and to respond to each question accordingly. For all items with a sliding
visual analog scale no numbers were visible to the participant and responses were rescaled to 0100 scale.
Fatigue
Daily fatigue was measured with the item “How fatigued did you feel today?” from no
fatigue to worst possible fatigue on a sliding scale. The item was adapted from the FSI (Hann et
al., 1998). Higher scores indicated worse fatigue. Daily fatigue was used as an outcome variable
for Aim 1.
Subjective cognitive function
Three items concerning daily subjective cognitive function included: was your mind as
sharp as usual, memory as good as usual, and thinking as fast as usual. These questions have
been used in a previous study (Mogle et al., 2017; Scott et al., 2015) and are similar to items
from the FACT-Cog (Chelune et al., 1986). Special instructions were provided for this question
during phone training at the in-person visit. Usual functioning was treated as the recent past,
within the past two weeks, rather than before cancer. Responses ranged from not at all to very
much and were specified on a sliding scale. Higher ratings indicate better subjective cognitive
performance. The three items were highly correlated (see Table 1), therefore a daily composite
was calculated by taking the mean of mental sharpness, memory, and thinking speed each day
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for each participant. Daily subjective cognitive function composite was used as outcome variable
for Aim 2.
Auxiliary daily variables
Mood
Daily mood was assessed with positive and negative affect means. All items were rated
using a sliding scale. Daily positive affect was measured with 4 items (happiness, joyfulness,
how pleased, and enjoyment). Happiness, joyfulness, and how pleased items were rated from not
at all to extremely; enjoyment was rated from not at all to very much on a sliding scale. Higher
scores indicated higher levels of positive affect (i.e., better mood). Daily negative affect was
measured with 5 items (anxiety, depression, anger, unhappiness, and frustration). Negative affect
items were rated from not at all to extremely on a sliding scale. Higher scores indicated higher
levels of negative affect (i.e., worse mood). Daily means of positive and negative affect were
obtained by averaging responses across respective items that day.
Physical activity
To assess daily physical activity the question “how much time did you spend doing
moderate to vigorous activities today, these are activities that make you breathe somewhat harder
than normal or much harder than normal” was presented. Participants were instructed to only
include activities that were engaged in for at least 10 minutes at a time. Drop down menus for
both hours (0-12) and minutes (5 minute increments) were used to indicate time spent doing
physical activity that day. Total time spent engaging in activity was converted from hour-minute
format to minutes per day.
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Overall physical health
Daily overall physical health was assessed with the item “overall how have you felt
physically today” rated from very unhealthy to very healthy on a sliding scale. Higher scores
indicated better perceived physical health.
Pain
The physical symptom of daily pain was assessed with the item “how much pain did you
feel today” and responses ranged from no pain to worst possible pain on a sliding scale. Higher
ratings indicated more pain that day.
Memory lapses
Participants were instructed to check all memory lapses that occurred that day, prompted
by the question “did you forget any of the following today?” (Mogle, 2011). Options for memory
lapses were: an errand/chore, take a medicine, finish a task, appointment, why you entered a
room, someone’s name, where something was put, a word, important information, and other. A
response of none of the above indicated that the participant did not have a memory lapse that
day. Total number of lapse types was calculated by summing all items endorsed that day and was
used in analyses.
External memory aids
To assess the use of external memory aids participants were instructed to check all items
that were used to help remember information that day. A list of common memory aids was
presented: lists, reminder notes, appointment book, had someone else remind you, repeat in your
head, and none of these things. Memory aid usage was treated as a dichotomous variable, any
reported usage (one or more endorsed items) or no usage that day.
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Data Analysis
Demographic and clinical variables were examined to describe the sample. Summary
statistics were conducted to describe outcome variables (daily fatigue and daily subjective
cognitive function) and predictors. In addition, summary statistics on retrospective questionnaire
subscales (FSI and FACT-Cog) and daily subjective cognitive functioning questions (thinking as
fast as usual, memory as good as usual, and mind as sharp as usual), average number of memory
lapses, percentage of days that lapses were reported, frequency of each type of memory failure,
and severity of lapses were examined to describe the sample. Compliance was calculated for
each participant and the overall sample. The total number of usable completed surveys was
divided by the number of possible surveys. Analyses indicated that overall compliance for the
sample was 87.23% (574 completed/ 658 possible) for daily diary surveys.
Person-averages of daily predictor variables from the diary measures were calculated by
obtaining an individual’s mean across study days (Hoffman, 2015). Correlation analyses were
conducted to examine univariate associations between fatigue and diary (mood, physical activity,
pain, physical health) and in-person measures (age, education, time since treatment, FSI, CESD). Similarly, correlation analyses were also conducted to observe associations between
subjective cognitive function and diary (mood, fatigue, memory lapses, memory aid usage) and
in-person measures (age, education, time since treatment, FACT-Cog, CES-D). Person-averages
of daily predictors were used in correlation analyses.
Reactivity refers to the accuracy of responses and understanding of a construct that may
occur as familiarity with assessment increases (Bolger et al., 2003; Moskowitz et al., 2009).
Although little evidence exists to suggest this is a major concern to validity (Bolger et al., 2003),
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to account for measurement reactivity study day (sequence of days 1-14) was included as a
within-person covariate (Hoffman, 2015).
Centering of Variables
Recommendations for centering variables vary across the literature. While no one rule
applies to all MLM, general guidelines can be applied according to the research question of
interest. In the current study centered variables were used when doing so aids interpretation (e.g.
age, CES-D; P. J. Curran & Bauer, 2011; Hoffman & Stawski, 2009; Wang & Maxwell, 2015).
Between-person variables were grand-mean centered (i.e., the practice of subtracting a constant
from a raw variable), prior to analysis. First, the grand mean was obtained by calculating the
mean across all participants and then subtracted from the score of each participant. For example,
grand-mean centered (CES-Dgmc) was calculated as follows: CES-Dgmc = CES-D (of
individual participant) –CES-D (of sample) (P. J. Curran & Bauer, 2011; Hoffman & Stawski,
2009; Wang & Maxwell, 2015). Time since treatment was centered on shortest time since
treatment (6.17 months) and education was centered at 12 years to aid interpretation. Daily
predictors each have a meaningful zero (e.g., physical activity in minutes) and were used in their
raw, un-centered forms (Wang & Maxwell, 2015). Person-averages were grand-mean centered to
indicate individual differences in responses. Only the person-average of memory aid usage
(dichotomous variable) was used in its un-centered form (Wang & Maxwell, 2015).
Multilevel Modeling
Multilevel model analysis was conducted to investigate the predictors of daily fatigue and
subjective cognitive function. Daily diary surveys completed across the study (up to 14 per
participant) are nested within survivors, measurement occasions nested within individuals, and
MLM is recommended. Generalized mixed models were utilized, which include fixed and
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random effects (Bolger et al., 2003; P. J. Curran & Bauer, 2011; Hoffman & Stawski, 2009).
Missing data is common among daily diary studies due to repeated assessment and does not
exclude cases with missing data (Walls & Schafer, 2006). For example, if an assessment was not
completed the rest of that participant’s assessments will still be used. Therefore, differing
numbers of assessments and unequal time intervals across participants, due in part to missing
data or missed surveys do not violate the assumptions of MLM (Hox, 2010). Data were is
assumed to be missing at random and refers to missingness that is attributed to a predictable
source, such as other observations (Hoffman, 2015). Day of study (i.e., 1 – 14) was unable to
account for missing observations from daily diaries. To satisfy the missing at random assumption
maximum likelihood estimation was used for all models (Hox, 2010) and all complete
assessments from each participant were included in analyses. Proc Mixed (SAS Version 9.4) was
used to estimate all models. Daily variables contain both within and between-person variation.
Therefore, person-averages of daily predictors were included at the person-level in all models
that contained diary measures in order to help separate between and within effects (Hoffman &
Stawski, 2009). Unconditional models were estimated for each daily predictor as the outcome to
examine the variance at each level.
The MLM assumptions of normality, independence, and homogeneity of variance were
examined using previously established recommendations. Normality refers to the normal
distribution of level-1 and level-2 residuals. Histograms and probability plots were used to
visually inspect normality (Hoffman, 2015; Hox, 2010). Independence implies that residuals at
each level are unrelated and was examined visually via scatterplots (Hoffman, 2015). Lastly,
homogeneity of variance assumes equal variance within each level and was examined with
scatterplots (Hox, 2010).
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Aim 1
Aim 1 was to describe between person differences and within person variation in daily
fatigue collected at the end of each day. The influence of within person (day-level) predictors
(e.g., daily diary measures) and between person (person-level) predictors (e.g., person averages
of day-level predictors, in-person measures) on ratings of daily fatigue were examined. We
hypothesized that daily fatigue will exhibit both between person and within person variation.
Both daily negative affect and daily pain were hypothesized to be positively related to daily
fatigue. Daily physical activity was negatively associated with daily fatigue. Finally,
retrospective fatigue completed prior to the daily diary portion of the study will be positively
associated with daily fatigue.
MLM of increasing complexity were used to determine the predictors of daily fatigue.
First, an unconditional model with a random intercept and no predictors was conducted with
daily fatigue as the dependent variable (outcome). This model provided an estimate of the
intercept, which was the average daily fatigue across all participants and days (Hox, 2010). The
variance estimate of the intercept indicated whether individuals differ on daily reported fatigue
(Hayes, 2006). The within-person variance estimate indicated whether or not individuals vary
across days in daily reported fatigue. Intraclass correlation coefficients (ICC) was calculated to
examine the proportion of variance at the between-person and within-person level using variance
estimates from the unconditional model (Hox, 2010). The equation can be conceptualized as the
variance at a given level (between or within) over the total variance (between + within).
Successive models included time-varying and time-invariant predictors to account for the
variance at each level. Time-varying predictors were collected daily at each assessment and were
considered to vary across time (P. J. Curran & Bauer, 2011). Time-invariant predictors remained
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constant over time and can explain between-person variance (P. J. Curran & Bauer, 2011). Using
this as a general framework, predictor variables were added at the day-level (varies) or personlevel (does not vary). To examine the impact of diary measures on daily fatigue Model 2
included fixed effects for daily negative affect, daily positive affect, daily overall physical health,
daily physical activity, daily pain, and study day at the day-level. The daily predictors were
entered into the model un-centered. These represent the within-person influences on daily
fatigue. To account for individual differences in daily predictors, grand-mean centered personaverages of these predictors were also included. Estimates from Model 2 indicate the relationship
between diary measures and daily fatigue. Model 3 examined fixed effects for person-level
predictors: demographic (age, education) and clinical characteristics (time since treatment), the
FSI intensity subscale, and depressive symptoms collected during the in-person visit in addition
to the Model 2 predictors. All person-level predictors were grand-mean centered. Estimates
indicated the relationship between the person-level predictors and daily fatigue across the study.
Model fit was examined using a Chi-square goodness of fit test with the change in -2 loglikelihood and the difference in the number of model parameters as the degrees of freedom
(Hoffman & Stawski, 2009) indicated which model explains the data best. Each subsequent
model was compared to the previous model. If the result was significant the more complex
model (more parameters) was chosen. The simpler model (fewer parameters) should be retained
if the result was not significant. In addition, AIC and BIC fit indices were examined to determine
the most appropriate model (Hoffman, 2015). Although not a true measure of model fit pseudo
R2 was calculated to determine the amount of variance explained by each successive model
(Singer & Willett, 2003).
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Aim 2
Aim 2 described between-person differences and within-person variation in daily
subjective cognitive functioning composite (thinking as fast as usual, memory as good as usual,
and mind as sharp as usual) collected at the end of each day. The influence of within-person
(day-level) predictors (e.g., daily diary measures) and between-person (person-level) predictors
(e.g., person means of day-level predictors, in-person-measures) on ratings of daily subjective
cognitive function were examined. We hypothesized that daily subjective cognitive function will
exhibit both between person and within person variation. Daily ratings of fatigue, memory
lapses, and negative affect were negatively associated with daily subjective cognitive function.
Lastly, retrospective cognitive function and depressive symptoms prior to the daily diary portion
of the study were hypothesized to be positively associated with daily subjective cognitive
function.
Successive MLMs were conducted to determine the predictors of daily subjective
cognitive function. As described in Aim 1, an unconditional model was estimated with daily
subjective cognitive function as to outcome and the ICC was calculated. In Model 2 fixed effects
of daily negative affect, daily positive affect, daily fatigue daily memory lapses, daily use of
memory aids, and study day represented within-persons influences on daily subjective cognitive
function. The daily predictors were entered into the model un-centered. Person-averages of daily
predictors were included as between-person influences on daily subjective cognitive function.
Model 2 estimates indicated the relationship between day-level predictors and daily subjective
cognitive function.
In Model 3 age, education, time since treatment, FACT-Cog (total score), and depressive
symptoms collected during the in-person visit were examined in addition to the Model 2
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predictors. All person-level predictors were grand-mean centered, with the exception of memory
aid usage. Estimates indicated the relationship between the person-level predictors and daily
subjective cognitive function across the study. As described in Aim 1, model fit was examined
using a Chi-square goodness of fit test, and AIC and BIC fit indices (Hoffman & Stawski, 2009)
and pseudo R2 was calculated.
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Figure 3.1 Participant recruitment and enrollment.
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Recruitment:
Sent a letter or
approached in
clinic
Eligibility:
Female, 40-65
years old, treated
for stage 0, 1, or 2
breast cancer at
Moffitt, ≥4 cycles
of chemotherapy,
completed
treatment 6-36
months ago, no
recurrence

Screen and
Schedule:
Those who did not
opt out are called
by research staff
Screened to
confirm eligibility,
verbal consent to
participation, and
scheduled inperson visit

In-person Visit:
Provided Informed
Consent
Completed
neuropsychological
tests and selfreport surveys
Trained on study
protocol and
smartphones

EMA and Daily
Diary:
Carried study
smartphones for 14
days
Answered brief
surveys and
cognitive
assessments each
day

Figure 3.2. Study design, how participants moved through the study. EMA= Ecological momentary assessment.
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End of Study
Phone Return
and Payment:
Equipment mailed
back via postage
paid boxes
Upon return
compliance was
confirmed and
payment sent
(Maximum: $110
for completing
study, incentives
for completing
80% of surveys)

Person-level (In-person
Questionnaires):
FSI
FACT-Cog
CES-D
Demographics
Clinical Characteristics

Day-level (Daily Diary
Surveys):
Fatigue (Outcome)
Subjective Cognitive
Function (Outcome)
Mood
Pain
Physical Activity
Memory Lapses
Memory Aid Usage

Figure 3.3. Description of data collection at each level of the study and specific information collected. FSI = Fatigue Symptom
Inventory; FACT-Cog = Functional Assessment of Cancer Treatment - Cognitive; CES-D = Center for Epidemiological StudiesDepression.
.
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Table 3.1
Intercorrelations among Subjective Cognitive Function Variables
Variable
1. Thinking as fast as usual

1
-

2

2. Mind as sharp as usual

.83*

-

3. Memory as good as usual

.86*

.87*

Note. N = 47; * = p < .001.
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3

-

Chapter Four: Results
The purpose of the present study was to examine daily quality of life concerns among
breast cancer survivors. Demographic characteristics of the sample are presented first, including
daily diary compliance. Next, the first aim described between-person differences and withinperson variation in daily fatigue collected at the end of the day. Additionally, day-level and
person-level predictors were examined. Aim 2 described between-person differences and withinperson variation in daily subjective cognitive functioning collected at the end of the day. The
associations of day-level and person-level predictors were examined.
Sample Characteristics
Sample characteristics are presented in Table 4.1. Briefly, 47 female breast cancer
survivors who were an average age of 53.34 years (SD = 6.46; range = 40.79-64.54), and were
also 17.07 months (SD = 7.23; range = 6-36) post-chemotherapy treatment comprised the final
sample. Ninety-eight percent of the sample completed at least high school. Seventy-nine percent
of the sample was white and 85% were Non-Hispanic or Latino. Descriptive statistics for study
variables are presented in Table 4.2 (in-person measures) and Table 4.3 (dairy measures).
Compliance was examined prior to completing analyses related to the study aims. A total
of 658 daily diary surveys were possible (47 participants for 14 days). In all, 677 surveys were
completed by participants. Seventy surveys were completed outside of the two week study
period, launched on the training day (before the 14 day study period began) or after the study
period ended and were excluded. Additionally, 33 were duplicates in which more than one
survey was completed on the same day. This was determined by examining survey times and
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excluded if completed in place of a beeped survey (e.g., if diary survey was completed prior to,
or in place of, the last beeped survey of that day likely the participant accidently launched a diary
survey rather than a beeped when she received the prompt) or after 4 AM (e.g., the cutoff
selected for participants with late bedtimes). Average compliance was 87.23% (~12.2 surveys;
574 usable/ 658 possible; range = 7.14% - 100%, Mdn = 92.86%) for daily diary surveys
completed at the end of the day (see Table 4.4 for a breakdown of compliance). We examined
the influence of participants with low compliance (i.e., less than 50% of survey completed).
Results remained the same when low compliance individuals were included. To not bias our
findings, and represent of individuals with low compliance, these participants were included in
analyses.
Aim 1 – Daily Fatigue
To examine the predictors of daily fatigue, diary measures and in-person measures were
utilized. Both day-level and person-level predictors from diary measures were included. Daily
predictors were un-centered and grand-mean centered person-averages of each of these daily
variables were also included to disentangle between and within effects. All daily variables
showed significant variability within-persons across days and between-persons (ps < .001) and
ICCs are displayed in Figure 4.1. The majority of variance (> 50%) was between-persons for all
daily variables. In-person measures were grand-mean centered.
Correlations between daily fatigue and predictor variables are shown in Table 4.5.
Person-averages of daily variables were utilized when calculating correlations. Fatigue had
positive correlations with negative affect and physical activity. Fatigue had a negative correlation
with positive affect. Demographic and clinical characteristics, such as retrospective fatigue
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severity during the prior week and depressive symptoms, had positive correlations with fatigue.
Age, education, and time since treatment were not correlated with fatigue.
Fatigue Multilevel Model Results
Normality, independence, and homogeneity of variance assumptions were evaluated for
each model that examined the predictors of daily fatigue. Histogram and probability plots
indicated that residuals appeared to be normally distributed. Independence and homogeneity of
variance assumptions did not appear to be violated as indicated by scatterplots.
Results for all daily fatigue models are displayed in Table 4.6. To determine if ratings of
daily fatigue exhibit both between person and within person variation an unconditional model
was conducted. The intraclass correlation coefficient (ICC) indicated that 67.8% of variance in
daily fatigue was between individuals and 32.1% of the variance was within persons. The
unconditional model showed that mean fatigue across days was 35.23 (SE = 3.26, p < .001) and
on average survivors differed in daily reports of fatigue, SD = 21.87, Z = 4.62, p < .001.
The effects of within- and between-person predictors from the diary measures were
examined in Model 2. Daily variables included mood (negative affect, positive affect), pain,
physical activity, and overall physical health collected each day; we also included the grand
mean-centered person averages of each of these variables. Within-person daily fluctuations in
negative affect, pain, and overall physical health were significant predictors of daily fatigue. On
days when a survivor reported higher negative affect, she tended to report greater fatigue that day
(b = 0.18, SE = 0.07, p = .007). Reporting higher pain was related to reporting higher fatigue that
day (b = 0.31, SE = 0.06, p < .001). Finally, on days when worse overall physical health was
experienced higher fatigue was reported that day (b = -0.14, SE = 0.05, p = .002). Daily
fluctuations in positive affect and moderate to vigorous physical activity did not predict
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fluctuations in fatigue. Study day was unrelated to daily fatigue ratings. No between-person
effects (person-averages) were related to daily fatigue across the study. Chi-square goodness of
fit test (χ2 (11) = 111, p < .05), suggests that Model 2 should be retained. A pseudo R2 that
compared a model that included diary measures to the unconditional model revealed that 59% of
the variation of daily fatigue was explained at the between-person level and 13% was explained
at the within-person level.
Demographic and clinical variables (i.e., age, education, time since treatment,
retrospective fatigue, and depressive symptoms) collected from in-person measures were
included in Model 3 to help account for between-person variation in addition to the diary
measures. Individual differences prior to the study in fatigue severity the week prior to the diary
phase of the study and time since treatment were a significant predictors of average daily fatigue.
As expected, persons who reported greater fatigue severity on the in-person measure also rated
average daily fatigue as greater across the study (b = 1.16, SE = 0.30, p < .001). Greater time
since treatment was related to higher fatigue across the study (b = 0.55, SE = 0.26, p = .044).
Age, education, and depressive symptoms from the in-person measures were unrelated to
average daily fatigue.
Day-level effects remained significant after all measures were included in the combined
model (Model 3). When survivors reported higher negative affect and pain then fatigue was rated
as higher that day. In contrast, on days when better overall physical health was reported related
to lower fatigue. The within-person effect of reporting 1 unit higher daily negative affect was
related to reporting higher fatigue by 0.18 that day (b = 0.18, SE = 0.07, p = .02). Within person
fluctuations in pain predicted daily fatigue - reporting 1 unit higher pain than average was related
to reporting higher fatigue by 0.31 that day (b = 0.31, SE = 0.06, p < .001). Last, the within-
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person effect of overall health on daily fatigue was significant (b = -0.15, SE = 0.05, p = .002).
On days when worse overall health was reported fatigue was rated as higher. Daily fluctuations
in positive affect and physical activity did not predict fluctuations in daily fatigue. Study day was
unrelated to daily fatigue ratings. Individual differences in person-averages of daily predictors
were unrelated to fatigue across the study. Chi-square goodness of fit test (χ2 (5) = 20.1, p < .05),
suggests that Model 3 should be retained. Including retrospective questionnaires and
demographic and clinical characteristics explained the data significantly better than the previous
model. A pseudo R2 that compared the full model to a model without demographic and clinic
characteristics revealed that 38% of the variation of daily fatigue was explained at the betweenperson level.
Aim 2 – Daily Subjective Cognitive Function
To examine the predictors of daily subjective cognitive function (i.e., a composite of
memory as good, thinking as fast, and mind as sharp), diary measures and in-person measures
were utilized. Diary measures were included as day-level and person-level predictors. Day-level
predictors were un-centered and person-level predictors were included as grand-mean centered
person-averages, with the exception of the dichotomous variable for memory aid usage. ICCs for
daily variables are displayed in Figure 4.1, variability within-persons across days and betweenpersons was significant (ps < .001). All in-person measures were grand-mean centered.
Correlations among subjective cognitive function and predictor variables are displayed in
Table 4.7. Person-averages of daily variables were utilized when calculating correlations.
Subjective cognitive function had negative correlations with diary measures of negative affect,
fatigue, memory aid usage, and memory lapses. Subjective cognitive function had a positive
correlation with positive affect. Demographic and clinical characteristics were correlated with
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subjective cognitive function. Retrospective subjective cognitive function prior to the study had a
positive correlation with subjective cognitive function. In contrast, depressive symptoms prior to
the study had a negative correlation with subjective cognitive function. Age, education, and time
since treatment were not correlated with subjective cognitive function.
Subjective Cognitive Function Multilevel Model Results
Normality, independence, and homogeneity of variance assumptions were evaluated for
each model. Histogram and normal probability plots were used to evaluate normality. Residuals
appeared to be normally distributed. Similarly, the independence and homogeneity of variance
assumptions did not appear to be violated as indicated by scatterplots.
Results for all daily subjective cognitive function models are displayed in Table 4.8. To
determine if ratings of subjective cognitive function made at the end of the day exhibit both
between person and within person variation the unconditional model was examined. The ICC
indicated that 69.7% of variance in daily subjective cognitive function was between individuals
and 30.3% of the variance was within persons. The unconditional model showed that mean
subjective cognitive function across days was 61.56 (SE = 2.44, p < .001). Survivors differed on
average in daily subjective cognitive function, SD = 16.42, Z = 4.49, p < .001.
The effects of within-person and between-person predictors from the diary measures
were examined in Model 2. Study day was associated with daily subjective cognitive function.
For each additional day in the study, subjective cognitive function was rated as better that day (b
= 0.31, SE = 0.11, p = .005). Daily variables included mood (negative affect, positive affect),
fatigue, memory aid usage, and memory lapses collected each day; person-averages of each of
the daily variables were also included. Within-person variability in positive affect, fatigue, and
memory lapses related to daily subjective cognitive function. On days when a survivor reported
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higher positive affect, she tended to report better subjective function that day (b = 0.20, SE =
0.05, p < .001). On days when a survivor reported higher fatigue, she tended to rate her
subjective cognitive function worse (b = -0.15, SE = 0.03, p < .001). Reporting more types of
memory lapses was related to reporting worse subjective cognitive function that day (b = -1.62,
SE = 0.42, p < .001). Daily fluctuations in negative affect and memory aid usage did not predict
fluctuations in subjective cognitive function. Between-person effects for diary measures were
also observed. Overall, survivors who reported greater positive affect on average also rated
subjective cognitive function as better across the study (b = 0.32, SE = 0.13, p = .019). No other
significant between-person effects were found. Chi-square goodness of fit test (χ2 (11) = 128.7, p
< .05), suggests that Model 2 should be retained. A pseudo R2 that compared a model that
included diary measures to the unconditional model revealed that 65% of the variation of daily
subjective cognitive function was explained at the between-person level and 14% was explained
at the within-person level.
Demographic and clinical variables (e.g., age, education, time since treatment,
retrospective subjective cognitive function the week prior to the study, depressive symptoms)
collected from in-person measures were included in Model 3 to help account for between-person
variation in addition to the diary measures. Individual differences in demographic and clinical
variables from the in-person measures were unrelated to subjective cognitive function.
Day-level effects remained significant after all measures were included in the combined
model (Model 3). Study day was associated with daily subjective cognitive function. For each
additional day in the study, subjective cognitive function was 0.31 units higher that day (b =
0.31, SE = 0.11, p = .005). Daily fluctuations in positive affect, fatigue, and memory lapses
significantly predicted daily fatigue. Within persons, positive affect was related to better
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subjective cognitive function. For every one-unit higher positive affect, subjective cognitive
function was 0.20 units higher that day (b = 0.20, SE = 0.05, p < .001). Greater fatigue was
associated with worse subjective cognitive function within persons. For every 1 unit higher
fatigue, subjective cognitive function was 0.15 lower that day (b = -0.15, SE = 0.03, p < .001).
Within persons, for each additional type of memory lapse reported subjective cognitive function
was expected to decrease by 1.62 that day (b = -1.62, SE = 0.42, p < .001). For a survivor with
1.76 more types of memory lapses than the sample average (+1 SD), her average subjective
cognitive function was 6.13 units lower than the average in the sample. Daily fluctuations in
negative affect and memory aid usage did not predict fluctuations in subjective cognitive
function. No significant between-person effects were found for these variables. The betweenperson positive affect effect was no longer associated with subjective cognitive function, which
was significant in the previous model. Chi-square goodness of fit test (χ2 (5) = 3.6, p > .05),
suggests that Model 2 should be retained. Including retrospective questionnaires and
demographic and clinical characteristics did not explain the data significantly better than the
previous model. A pseudo R2 that compared the full model to a model without demographic and
clinic characteristics revealed that 8% of the variation of daily subjective cognitive function was
explained at the between-person level.
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Table 4.1
Participant Characteristics

Characteristic

Total Sample
(n = 47)
M (SD)
% (n)

Age

53.34 (6.46)

Time since treatment (in months)

17.07 (7.23)

Breast Cancer Stage
Stage I
Stage II

25.53 (12)
74.47 (35)

Education
Some high school
Completed high school or GED
Some college
Completed college
Graduate or professional degree

2.13 (1)
17.02 (8)
31.91 (15)
25.53 (12)
23.40 (11)

Race
White
Black
Asian
Other

78.72 (37)
14.89 (7)
4.26 (2)
2.13 (1)

Ethnicity
Non-Hispanic/Latino
Hispanic/Latino
Unknown

82.98 (39)
14.89 (7)
2.13 (1)

Work Status
Employed
Retired
Unemployed

48.94 (23)
31.91 (15)
19.15 (9)

Marital Status
Married
Divorced or separated
Un-married
Other

68.08 (32)
19.15 (9)
10.64 (5)
2.13 (1)
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Table 4.1 (Continued)

Characteristic

Total Sample
(n = 47)
M (SD)
% (n)

Household Income
Less than 4,999
5,000-19,999
20,000-39,999
40,000-59,999
60,000-79,999
80,000-99,999
100,000-149,999
150,000 or more
Chose not to answer
Missing

4.26 (2)
8.51 (4)
10.64 (5)
12.77 (6)
4.26 (2)
12.77 (6)
10.64 (5)
12.77 (6)
8.51 (4)
14.89 (7)

Note. For age the range = 40.91-64.58 years and for time since treatment the range = 6.17-36.40
months.
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Table 4.2
Summary Statistics for In-Person Measures

Measure
Pre-Study Paper Questionnaires
FSI
FSI severity
FSI interference
FSI frequency
FACT – Cog
FACT perceived cognitive
impairments
FACT quality of life
FACT comments from others
FACT perceived cognitive
abilities
FACT total score
CES-D total score

Total Sample
(n = 47)
M (SD)
% (N)

Range

13.45 (8.35)
14.99 (15.61)
3.36 (2.27)

0-28
0-56
0-7

54.16 (16.78)

6-80

12.23 (4.43)
14.38 (2.50)
24.64 (9.50)

0-16
6-16
5-36

105.41 (30.36)
11.81 (7.94)

21-148
3-41

Note. FSI = Fatigue Symptom Inventory; FACT = Functional Assessment of Cancer Treatment;
CES-D = Center for Epidemiological Studies-Depression; Range is the observed range in the
sample.
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Table 4.3
Summary Statistics for Daily Diary Measures

Measure
End of Day Smartphone
Surveys
Fatigue
Fatigue severity
Fatigue interference
Subjective cognitive function
Mind as sharp
Memory as good
Thinking as fast
Composite
Memory lapses
Memory lapse by type
Chore
Task
Why entered a room
Medication
Appointment
A word
Where something was put
Someone’s name
Information
Other
More than one
None
Total lapses per day
Memory lapse severity
Bother
Interfere
Future consequences
Severity
Memory aid usage
Lists
Notes
Book
Someone
Repeat
No aid
Any used
Pain

Total Sample
(n = 47)
M (SD)
% (N)

Range

33.96 (26.57)
26.49 (26.28)

0-100
0-100

62.07 (21.20)
62.00 (21.38)
62.13 (20.66)
62.06 (20.03)

0-100
2-100
0-100
8.7-100

12.37 (71)
18.29 (105)
16.72 (96)
11.32 (65)
3.48 (20)
21.25 (122)
19.16 (110)
13.76 (79)
9.06 (52)
10.98 (63)
35.19 (202)
42.33 (243)
1.42 (1.76)

0-9

25.28 (28.77)
14.41 (21.03)
23.29 (29.59)
20.99 (23.27)

0-100
0-96
0-99
0-97.5
33.97 (195)
28.22 (162)
24.22 (139)
12.02 (69)
17.25 (99)
38.33 (220)
61.67 (354)

19.72 (26.76)
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Table 4.3 (Continued)

Measure
Physical activity (minutes)
Sitting (minutes)
Mood
Positive affect
Negative affect

Total Sample
(n = 47)
M (SD)
% (N)

Range

93.14 (111.01)
419.98 (166.91)

0-618
0-778

65.33 (18.81)
16.24 (17.07)

6-100
0-81

Note. Range is the observed range in the sample; Memory lapses were reported via checklists
each night; Frequencies are across all participants over the 14 day ecological momentary
assessment study. Memory lapse severity questions bother, interfere, and future consequences
were only asked if a memory lapse was reported.
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Table 4.4
Participant Compliance for Daily Diary Surveys
Number of Daily Diary
Surveys completed

N

%

Cumulative %

100%
90%-99%
80%-89%
70%-79%
60%-69%
50%-59%
< 50%

17
12
7
5
4
0
2

36.17
25.53
14.89
10.64
8.51
0
4.26

36.17
61.70
76.59
87.23
95.74
95.74
100

Note. Breakdown of participant compliance for daily diary surveys across the 14 day study.
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100
90
80

Variance (%)

70
60

Between-person
Variance

50
40

Within-person
Variance

30
20
10
0
Fatigue

Subjective
cognitive
function

Positive affect

Negative
affect

Physical
activity

Pain

Physical
health

Memory
lapses

Memory aids

Daily Variables

Figure 4.1. Variance of daily predictors from the daily diary surveys. Breakdown of within- and between-persons variance in daily
variables (day-level). ICCs were calculated from individual unconditional models run for each daily variable.
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Table 4.5
Correlations among Daily Fatigue and Predictors
Variable

1

1. Daily fatigue

-

2. Daily negative affect
3. Daily positive affect

.53**

2

3

4

5

6

-.44** -.49**

9

10

11

12

-

.70**

.42**

-.38**

5. Daily sitting

-.06

.12

-.07

.25

-.08

-.05

.39**

-.11

-

.29*

8

-

4. Daily pain

6. Daily physical activity

7

-

7. Daily physical health

-.58** -.58**

.67**

.57**

-.19

.02

-

8. Age

-.12

-.22

.15

-.01

.07

.05

.10

-

9. Education

-.07

-.11

-.37*

-.15

-.07

-.16

-.24

-.41**

10. Time since treatment

.20

.10

-.14

.05

.27

-.11

-.24

11. FSI severity

.71**

.43**

-.46**

.51**

.02

.13

12. CES-D

.68**

.59**

-.39**

.68**

.21

.24

-

.01

.03

-

-.46**

-.28

-.07

.03

-

-.48**

-.09

-.11

-.02

.59**

Note. Within person correlations (N = 47); FSI = Fatigue Symptom Inventory; CES-D = Center for Epidemiological StudiesDepression.
* p < .05. ** p < .01.
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Table 4.6
Fixed and Random Effects of Daily Fatigue
Model 1
(Unconditional)
Estimate (SE)

Model 2
(Diary
Measures)
Estimate (SE)

Intercept

35.23** (3.26)

33.63** (6.11)

30.41** (7.34)

Level 1 (day)
Study day
Negative affect
Positive affect
Vigorous activity
Pain
Overall physical
health

-

0.15 (0.15)
0.18* (0.07)
0.02 (0.07)
-0.01 (0.01)
0.31** (0.06)
-0.14* (0.05)

0.15 (0.15)
0.18* (0.07)
0.02 (0.07)
-0.003 (0.01)
0.31** (0.06)
-0.15* (0.05)

Fixed Effects

Level 2 (person)
Negative affect –
person average
Positive affect –
person average
Vigorous activity –
person average
Pain – person
average
Overall physical
health – person
average
Age
Time since treatment
FSI severity
CES-D total
Education

Model 3
(Diary + Inperson Measures
Estimate (SE)

-

0.27 (0.23)

0.11 (0.21)

-

-0.06 (0.21)

0.10 (0.18)

-

0.03 (0.03)

0.04 (0.02)

-

0.05 (0.13)

-0.12 (0.12)

-0.11 (0.22)

-

-

0.001 (0.19)

0.19 (0.35)
0.55* (0.26)
1.16** (0.30)
0.39 (0.36)
0.47 (0.92)

Random effects
N, Level 2
N, Level 1
Intercept (τ00)
Residual (σ2)

47
574
478.37**
227.60**

47
574
197.14**
198.71**

47
574
121.90**
198.73**

Fit Statistics
Deviance (-2LL)
AIC

4896.8
4902.8

4785.8
4811.8

4765.7
4801.7
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Table 4.6 (Continued)
Model 1
(Unconditional)

Model 2
(Diary
Measures)

Model 3
(Diary + Inperson Measures

BIC

4908.3

4835.9

4835.0

Pseudo-R2
Between individuals
Within individual

-

.59
.13

.38
-

Note. Unstandardized parameter estimates were displayed; Level 2 variables were grand-mean
centered; FSI = Fatigue Symptom Inventory; CES-D = Center for Epidemiological StudiesDepression.
* p < .05. ** p < .01.
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Table 4.7
Correlations among Daily Subjective Cognitive Function and Predictors
Variable
1. Daily subjective
cognitive function

1

2

3

4

5

6

7

8

9

10

11

-

2. Daily negative affect

-.48**

-

3. Daily positive affect

.65**

-.49**

-

4. Daily fatigue

-.62**

.53**

-.44**

-

5. Daily memory aid usage

-.36*

.28

-.44**

.41**

-

6. Daily memory lapse

-.58**

.51**

-.39**

.56**

.42**

7. Age

.11

-.22

.15

-.12

.26

.05

-

8. Education

-.14

.04

-.26

-.15

.01

-.07

-.35*

9. Time since treatment

-.21

.10

-.14

.20

.10

.07

.01

-.10

-

10. FACT-cog

.41**

-.49**

.31*

-.59**

-.34*

-.77**

.15

.16

.06

-

11. CES-D

-.46**

.58**

-.39**

.68**

.30*

.63**

-.09

-.17

-.02

-.79**

-

-

-

Note. Within person correlations (N = 47); EOD = end of day; FACT-cog = Functional Assessment of Cancer Treatment cognitive
subscale; CES-D = Center for Epidemiological Studies-Depression.
* p < .05. ** p < .01.
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Table 4.8
Fixed and Random Effects of Daily Subjective Cognitive Function
Model 1
(Unconditional)
Fixed Effects
Intercept

Estimate (SE)
61.56** (2.44)

Model 2
(Diary
Measures)
Estimate (SE)
55.06** (5.10)

Level 1 (day)
Study day
Negative affect
Positive affect
Fatigue
Memory aid usage
Memory lapses

-

0.31** (0.11)
-0.01 (0.05)
0.20** (0.05)
-0.15** (0.03)
-0.53 (1.27)
-1.62** (0.42)

-

0.12 (0.16)

0.13 (0.17)

-

0.32* (0.13)

0.26 (0.14)

-

-0.10 (0.09)

-0.13 (0.10)

-

3.99 (5.16)

3.08 (5.46)

-

-1.89 (1.39)

-3.61 (1.83)

Level 2 (person)
Negative affect –
person average
Positive affect –
person average
Fatigue – person
average
Memory aid usage –
person average
Memory lapses –
person average
Age
Education
Time since treatment
FACT total
CES-D total

-

-

Model 3
(Diary + Inperson Measures)
Estimate (SE)
58.29** (6.00)

0.31** (0.11)
-0.01 (0.05)
0.20** (0.05)
-0.15** (0.03)
-0.53 (1.27)
-1.62** (0.42)

0.12 (0.31)
-0.51 (0.70)
-0.09 (0.22)
-0.12 (0.10)
-0.08 (0.35)

Random effects
N, Level 2
N, Level 1
Intercept (τ00)
Residual (σ2)

47
574
269.47**
117.21**

47
574
93.46**
100.39**

47
574
85.68**
100.41**

Fit Statistics
Deviance (-2LL)
AIC
BIC

4519.9
4525.9
4531.5

4391.2
4417.2
4441.2

4387.6
4423.6
4456.9
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Table 4.8 (Continued)
Model 1
(Unconditional)
Pseudo-R2
Between individuals
Within individual

-

Model 2
(Diary
Measures)
.65
.14

Model 3
(Diary + Inperson Measures)
.08
-

Note. Unstandardized parameter estimates are displayed; Level 2 were grand-mean centered
with the exception of memory aid usage; FACT = Functional Assessment of Cancer Treatment;
CES-D = Center for Epidemiological Studies-Depression.
* p < .05. ** p < .001.
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Chapter Five: Discussion
As cancer survival rates continue to increase there is a need to focus on life after cancer.
Self-reports of memory and attention difficulties and fatigue are common quality of life concerns
for breast cancer survivors but less is known regarding prevalence and predictors of these
problems in daily life. This dissertation expanded the literature on fatigue and subjective
cognitive function after cancer treatment using data from daily diary assessments. Specifically,
our findings highlight both which individuals are at risk for high levels of fatigue and subjective
cognitive problems in daily life and types of days when fatigue is higher and subjective cognitive
problems are worse. Further, QoL concerns were reported up to three years after treatment
among a sample of breast cancer survivors.
Daily Fatigue
The present study evaluated within-person and between-persons relationships between
daily fatigue and diary measures, as well as associations with in-person measures (e.g.,
retrospective questionnaires and demographic characteristics). Variability in daily fatigue was
largely between-persons (67.8%), attributed to individual differences. Diary measures explained
a substantial amount of the variance in daily fatigue, 59% between-persons and 13% withinpersons. Of the daily factors examined, greater negative affect and worse subjective physical
functioning were most consistently associated with fatigue. Previous research has linked fatigue
with negative affect (Carpenter et al., 2001) and worse physical function (S. L. Curran et al.,
2004; Mehnert et al., 2007) at the between-persons level, whereas our study detected withinperson influences on daily fatigue. As expected, at the within-person level, daily negative affect
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(i.e., depressive symptoms, anxiety, anger, unhappiness, and frustration) was associated with
daily fatigue. On days when survivors reported elevated levels of negative affect she also tended
to rate fatigue as higher.
Previous research has established an association between two aspects of physical function
- pain and general physical health - and fatigue (Jones et al., 2016; Servaes et al., 2007). At the
within-person level, pain was related to fatigue and was consistent with previous research (S. L.
Curran et al., 2004). That is, on days when survivors reported greater pain, they tended to also
report higher levels of fatigue that day. Our findings also support a concurrent, within-person
association between fatigue and a marker of physical health. At the within-person level, on days
when physical health was rated as better survivors also rated fatigue as lower.
Additionally, another aspect of daily physical function, physical activity, was examined
as a predictor of daily fatigue. Findings of no associations, within- or between-persons, between
physical activity and fatigue were contrary to expectations based on previous research (Jacobsen
et al., 2007; Minton et al., 2013; Mormont et al., 2000). The assessment of physical activity is a
potential explanation. We operationalized physical activity as the total amount of time (in
minutes) engaging in moderate to vigorous activity that day, which may not be a sensitive
enough measure of activity. For instance, participants were instructed to report any physical
activity when they were active for longer than 10 minutes at a time. Despite engaging in activity,
participants that did not reach the 10 minute threshold may report less activity or no activity that
day. Further, type of activity was not accounted for, only level of exertion, which may not
capture the entire experience. Objective measures of activity, such as those available from
wearable sensors, would contribute additional information about activity levels and provide a
comparison for self-report measures.
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Including between-person influences (e.g., demographic and clinical characteristics,
retrospective fatigue) from the in-person visit did not significantly change the relationships
between diary measures and daily fatigue. In regards to within-person findings, this suggests that
individual differences in demographic and clinical characteristics and retrospective
questionnaires did not account for within-persons associations. Between-person effects of the
person-averages of daily variables remained unrelated to daily fatigue across the study.
Individual differences in retrospective fatigue, corresponding to the week prior to the daily diary
portion of the study, were predictive of daily fatigue across the study. At the between-person
level, survivors who recalled higher levels of fatigue prior to the study tended to report higher
levels of fatigue across the two weeks. There are several possible explanations for this
consistency. Fatigue levels may be consistent across short periods of time (e.g., less than a
month). Another explanation is that fatigue a persistent problem for some survivors regardless of
the timeframe in which it assessed. Our finding of an association between time since treatment
was completed and fatigue was in contrast to previous studies that found no relationship
(Mehnert et al., 2007; Servaes et al., 2007). At the between-person level, survivors who had
completed treatment longer ago (in months) tended to report higher levels of fatigue. We did not
observe an association between daily fatigue and age, education, and depressive symptoms from
the week prior.
Daily Subjective Cognitive Function
Subjective cognitive function represented multiple aspects of daily cognition (i.e.,
memory, mental sharpness, and thinking speed) in the current study. We examined the withinperson and between-persons relationships between daily subjective cognitive function and diary
measures, along with associations with in-person measures (e.g., retrospective questionnaires and

68

demographic characteristics). The majority of the variance in daily subjective cognitive function
was between-persons (69.7%). Diary measures explained a substantial amount of variance in
daily subjective cognitive function, 65% between-persons and 14% within-persons. Of the daily
factors examined, positive affect, fatigue, and memory lapses were most consistently associated
with subjective cognitive function.
There is an extensive body of research connecting mood and fatigue to subjective
cognitive function among cancer survivors. From this research it is evident that at the betweenperson level, better mood is associated with better subjective cognitive function (Pullens et al.,
2010; Rey et al., 2012; Shilling & Jenkins, 2007). Our study found support for this relationship at
the within-person level. We found that on days when positive affect (the day mean of happiness,
joyfulness, pleasure, and enjoyment) was rated as higher, better subjective cognitive function
was reported. Fatigue is another well-established as a predictor of subjective cognitive function
(Mehnert et al., 2007; Rey et al., 2012; Ribi et al., 2012). Our study provides further support for
the connection and the understanding that tiredness and fatigue likely underlie cognition (Dijk et
al., 1992). At the within-person level, on days when higher levels of fatigue were reported
subjective cognitive function was rated as worse that day. Memory performance is one
component of subjective cognitive function, and potentially the easiest for participants to
identify. At the within-person level, memory lapses were associated with daily subjective
cognitive function. On days when a survivor reported more memory lapses she also rated
subjective cognitive function as worse.
In this study, between-person predictors from the diary and in-person measures were not
associated with subjective cognitive function. That is, person-averages of daily variables were
not associated with subjective cognitive function at the between-persons level, with the
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exception of positive affect in the model that included only diary measures. However, this
association was no longer significant when demographic and clinical characteristics were
included. Contrary to predictions, depressive symptoms and retrospective subjective cognitive
function corresponding to the week prior to the daily diary portion of the study were not related
to daily subjective cognitive function. In general, the timeframes of questionnaire measures and
daily diaries do not correspond to the same experiences which may make it difficult to observe
an association. That is, the retrospective questionnaire assessed the week prior to the daily diary
period. Our lack of an observed association with retrospective depressive symptoms could be the
inclusion of daily negative affect, which included depressive symptoms. That is, fatigue and
negative affect assessed on the same day are more closely related. In regards to retrospective
subjective cognitive function, another potential explanation is that the FACT-Cog total score
may have been too broad a measure. A subscale focusing on perceived cognitive abilities or
impairments may relate better to daily subjective cognitive function items used during the diary
portion of the study.
Individual differences in demographic and clinical characteristics (i.e., age, education,
and time since treatment completed) were also unrelated to daily subjective cognitive function
across the study. Time since treatment completed was unable to predict subjective cognitive
function experienced in daily life. Our study contributes to the body of literature that suggests the
course of subjective cognitive dysfunction is difficult to discern (Pullens et al., 2010). Taken
together, our findings do not suggest that individual differences in demographic and clinical
characteristics are able identify survivors at greater risk for worse subjective cognitive function.
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Function in Daily Life
Much of the previous research in survivorship has been limited to traditional in-person
measures with little focus on daily life. Findings from this study support the movement towards
examining function in natural settings, rather than relying on retrospective self-report measures.
Importantly, traditional measures largely ignore variations that occur across days, but commonly
rely on survivors’ self-assessments experiences that occurred over the past week. Responses
depend on an individual’s perception and recollection of the experience which is susceptible to
bias (P. C. Stone & Minton, 2008). Our study combined both diary data and retrospective
questionnaire data to examine the within- and between person influences on daily fatigue and
subjective cognitive function. We demonstrated that to better understand fatigue and subjective
cognitive function in daily life more frequent measurement, such as daily diaries, is required.
Strengths and Limitations
Strengths and limitations of this dissertation should be acknowledged. First, a strength
was the use of daily diary surveys that allowed us to follow survivors for 14 days and examine
QoL issues that occurred in natural settings. Daily diary surveys should reduce retrospective bias
by shortening reporting windows (A. A. Stone & Shiffman, 2002). Rather than participants
recalling fatigue over the past week they only had to recall experiences from that day. Our
methods allowed us to examine both individual differences and within-person fluctuations that
contributed to daily QoL issues. This is among the first studies to examine within-person
relationships between QoL issues and previously identified related factors (e.g., negative affect,
pain). Although daily fatigue and daily subjective cognitive function were measured with few
items, there was sufficient within-person variability to detect effects at the within-person level.
Another strength was that average compliance among this sample was close to 90%, although
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two participants completed less than 60% of surveys these participants were included in analyses
in order to represent individuals with low compliance. We also had no attrition during the 14 day
dairy study period, therefore there were no differences between participants that completed
versus those that did not.
Several limitations of our study should be acknowledged. First, our sample was female,
predominantly white, breast cancer survivors. This limits the generalizability to males, and to
other cancers. This is a widespread issue in survivorship research. However, the prevalence of
breast cancer and high rates of survival make it an ideal population to study. Expanding this
research to other cancers such as prostate and colorectal would remedy the issue and provide
information about how these issues operate in daily life across cancers.
Despite the majority of variance being between-persons few demographic, clinical, and
retrospective questionnaire variables were significant predictors of daily fatigue and subjective
cognitive function. We did not find any associations between demographic variables (i.e., age
and education) and daily variables of fatigue and subjective cognitive function. Our ability to
detect individual differences was partially dependent upon the number of level-2 units (Hoffman,
2015; Hox, 2010). That is, although we had 574 observations in total, we only had 47 survivors
for our tests of individual differences. In addition, a restricted age range and overall high
educational attainment of the sample may have reduced our ability to observe associations
between these demographic characteristics and daily QoL. An expanded age range that included
adults over the age of 65 would improve generalizability and provide important information
about older cancer survivors as this population continues to grow. An alternative explanation is
that daily reported measures were more consistently related to our daily outcomes indicating that
relationships at the same level (i.e., daily) were stronger and more predictive of outcomes. Daily
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experiences may have a greater influence over daily QoL. These relationships may occur on a
short time scale, and the daily variability is important. For example, variation in negative affect
across days is different than being higher in negative affect compared to others.
Another limitation was the time of measurement. In the current study we opted to use
diary surveys completed at the end of the day. Reports made at the end of the day are susceptible
to retrospective bias, although less so than traditional retrospective questionnaires. Recent or
peak (e.g., a time when pain was particularly high that day) events may influence reporting.
Additionally, daily variables were reported concurrently each night which does not permit us to
determine causation. The use of daily diaries, rather than the momentary data collected
throughout the day, captured variation across days but not variability throughout the day. Recent
evidence suggests that EMA and diary reports of mood, fatigue, and activities completed on the
same day were associated and similar (Kim, Kikuchi, & Yamamoto, 2013). Only small
differences in reports were detected, diary reports of activities were shorter in duration and
depression was higher compared to EMA reports (Kim et al., 2013). Lastly, no baseline data was
available to compare change. Therefore, we were only able to examine individual differences
and day-level effects.
Future Directions
Our results indicate areas where future work is needed. Fatigue not only interferes with
physical function, but may also impact daily subjective cognitive function (S. M. Phillips, Lloyd,
Awick, & McAuley, 2017). Moving forward, future work should explore the connections
between daily QoL issues. This information will be important for survivors that are experiencing
worse fatigue and subjective cognitive function in daily life compared other survivors.
Additionally, although only the retrospective fatigue questionnaire was a significant predictor of
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fatigue across the study there is utility in traditional validated measures. Retrospective fatigue
measures administered once could be used to determine which survivors should be followed with
daily diaries (i.e., those reporting higher fatigue compared to other survivors). The present
analyses were able to examine within-person and between-person associations. However,
assessments would ideally occur pre-treatment, during treatment, and after treatment has
completed to examine change. In addition, common risk factors such as pre-cancer cognitive
function, life-style factors, and genetic factors should be collected and controlled for when
available to help elucidate inconsistent relationships (Wefel et al., 2015).
Using methodologies currently available it is possible to survivors at highest risk for
issues in order to reduce long-term disability and improve QoL (Wefel et al., 2015). Currently,
interventions to improve cognitive outcomes post-treatment include web-based cognitive training
(Damholdt et al., 2016), increased physical activity and yoga (Derry et al., 2015), and
pharmacology (Wefel et al., 2015). One approach to delivering interventions is ecological
momentary intervention (EMI). EMI provides an intervention or tailored support (content and
timing) in the real-world where the target behavior occurs and has been used to increase physical
activity and reduce anxiety (Heron & Smyth, 2010). Our results indicated that daily mood
corresponds with fatigue and subjective cognitive function. A tailored intervention for breast
cancer survivors to increase positive affect and decrease negative affect could be beneficial.
Further, assessments can increase awareness of a behavior and potential triggers, track past
behaviors, and provide information about high risk contexts (Runyan & Steinke, 2015). Daily
diary assessments could be used in combination with EMI to improve daily fatigue and
subjective cognitive function among breast cancer survivors. Although delivering interventions
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in this form is likely the future, specific aspects of interventions still need to be determined (e.g.,
length of intervention, frequency and length of each assessment) (Runyan & Steinke, 2015).
Clinical Implications and Considerations
Our findings have clinical implications for breast cancers survivors experiencing
decreased QoL post-treatment. Daily variation in fatigue and subjective cognitive functioning
has received little attention in the existing survivorship research. Identifying sources of
variability will provide areas of daily life on which to intervene, and this study contributed to this
body of knowledge at the within-person level. Further, survivors want self-perceived changes,
especially subjective cognitive dysfunction, to be acknowledged by doctors and informed of
these potential changes prior to treatment (Boykoff et al., 2009). Appropriate coping methods
could then be provided to patients undergoing chemotherapy and after treatment. The questions
remain: who is best suited to provide care for post-treatment side-effects and when this care is
appropriate (Rowland & Bellizzi, 2014). Educating high risk survivors may begin at diagnosis to
inform patients on treatment decisions and the associated QoL issues. In the future, this will
guide treatment options and continue monitoring QoL during administration (Curt et al., 2000).
Further, understanding these relationships in daily life will be increasingly important as
cancer survivors age. Due to the aging of the population, increased cancer risk with age, and
improved survival rates, individuals over age 65 currently make up 2/3 of cancer survivors,
representing a significant public health concern (Bluethmann et al., 2016). Previous research has
also found the older breast cancer survivors report higher levels of anxiety, depression, and
fatigue and lower levels of QoL compared to healthy controls (Mandelblatt et al., 2014). These
self-reported experiences are associated with higher fatigue and worse subjective cognitive
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function, as demonstrated in this study. Future work should follow survivors as they age to
disentangle cancer- and age-related effects.
Summary
A primary goal of this dissertation was to examine QoL issues among a sample of breast
cancer survivors. Specifically, we focused on daily life after treatment when survivors
experience a decrease in physical, cognitive, and social function. We accomplished this using
data from daily diaries. Our findings suggest that diary surveys completed once per day were
able to capture the relationships between fatigue and subjective cognitive function and daily
reported experiences. Taken together, our findings represent long-term QoL issues that persists
up to 3 years after treatment for some survivors. Further research after treatment is needed to
address these issues.

76

References
ACS. (2018). Cancer facts and figures 2018. Atlanta: American Cancer Society.
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012). Cancer- and cancer treatment-associated
cognitive change: An update on the state of the science. Journal of Clinical Oncology,
30(30), 3675-3686. doi: 10.1200/JCO.2012.43.0116
Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced
cognitive changes. Nature Reviews Cancer, 7(3), 192-201. doi: 10.1038/nrc2073
Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., . . .
Kaufman, P. A. (2010). Longitudinal assessment of cognitive changes associated with
adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of
Clinical Oncology, 28(29), 4434-4440. doi: 10.1200/JCO.2009.27.0827
Ancoli-Israel, S., Liu, L., Marler, M. R., Parker, B. A., Jones, V., Sadler, G. R., . . . Fiorentino,
L. (2006). Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer.
Supportive Care in Cancer, 14(3), 201-209. doi: 10.1007/s00520-005-0861-0
Ancoli-Israel, S., Moore, P. J., & Jones, V. (2001). The relationship between fatigue and sleep in
cancer patients: A review. European Journal of Cancer Care, 10(4), 245-255.
Anstey, K. J., Sargent-Cox, K., Cherbuin, N., & Sachdev, P. S. (2015). Self-reported history of
chemotherapy and cognitive decline in adults aged 60 and older: The PATH through life
project. The Journals of Gerontology, Series A(6), 729. doi: 10.1093/gerona/glt195

77

Banthia, R., Malcarne, V. L., Roesch, S. C., Ko, C. M., Greenbergs, H. L., Varni, J. W., &
Sadler, G. R. (2006). Correspondence between daily and weekly fatigue reports in breast
cancer survivors. Journal of Behavioral Medicine, 29(3), 269-279. doi: 10.1007/s10865006-9053-8
Beaudoin, M., & Desrichard, O. (2011). Are memory self-efficacy and memory performance
related? A meta-analysis. Psychological Bulletin, 137(2), 211-241. doi:
10.1037/a0022106
Blatter, K., & Cajochen, C. (2007). Circadian rhythms in cognitive performance: Methodological
constraints, protocols, theoretical underpinnings. Physiology & Behavior, 90, 196-208.
doi: 10.1016/j.physbeh.2006.09.009
Bluethmann, S. M., Mariotto, A. B., & Rowland, J. H. (2016). Anticipating the "Silver
Tsunami": Prevalence trajectories and comorbidity burden among older cancer survivors
in the United States. Cancer Epidemiology, Biomarkers & Prevention, 25(7), 1029-1036.
doi: 10.1158/1055-9965.epi-16-0133
Bolger, N., Davis, A., & Rafaeli, E. (2003). Diary methods: Capturing life as it is lived. Annual
Review of Psychology, 54(1), 579.
Bower, J. E. (2014). Cancer-related fatigue--mechanisms, risk factors, and treatments. Nature
Reviews Clinical Oncology, 11(10), 597-609. doi: 10.1038/nrclinonc.2014.127
Bower, J. E., Ganz, P. A., A., D. K., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000).
Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life.
Journal of Clinical Oncology, 18(4), 743-743. doi: doi:10.1200/jco.2000.18.4.743
Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002). Fatigue and proinflammatory cytokine
activity in breast cancer survivors. Psychosomatic Medicine, 64(4), 604-611.

78

Bower, J. E., Ganz, P. A., Irwin, M. R., Kwan, L., Breen, E. C., & Cole, S. W. (2011).
Inflammation and behavioral symptoms after breast cancer treatment: Do fatigue,
depression, and sleep disturbance share a common underlying mechanism? Journal of
Clinical Oncology, 29(26), 3517-3522. doi: 10.1200/JCO.2011.36.1154
Bower, J. E., & Lamkin, D. M. (2013). Inflammation and cancer-related fatigue: Mechanisms,
contributing factors, and treatment implications. Brain, Behavior, and Immunity, 30(0),
S48-57. doi: 10.1016/j.bbi.2012.06.011
Boykoff, N., Moieni, M., & Subramanian, S. K. (2009). Confronting chemobrain: An in-depth
look at survivors' reports of impact on work, social networks, and health care response.
Journal of Cancer Survivorship(4), 223-232.
Carpenter, J. S., Gautam, S., Freedman, R. R., & Andrykowski, M. (2001). Circadian rhythm of
objectively recorded hot flashes in postmenopausal breast cancer survivors. Menopause,
8(3), 181-188.
Cavanaugh, J. C., Feldman, J. M., & Hertzog, C. (1998). Memory beliefs as social cognition: A
reconceptualization of what memory questionnaires assess. Review of General
Psychology, 2(1), 48-65. doi: 10.1037/1089-2680.2.1.48
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., . . . Brannon, J. (1993).
The Functional Assessment of Cancer Therapy scale: Development and validation of the
general measure. Journal of Clinical Oncology, 11(3), 570-579. doi:
10.1200/jco.1993.11.3.570
Chelune, G. J., Heaton, R. K., & Lehman, R. A. W. (1986). Neuropsychological and personality
correlates of patients’ complaints of disability. In G. Goldstein & R. E. Tarter (Eds.),
Advances in Clinical Neuropsychology (pp. 95-126). Boston, MA: Springer US.

79

Collins, B., MacKenzie, J., Tasca, G. A., Scherling, C., & Smith, A. (2013). Cognitive effects of
chemotherapy in breast cancer patients: A dose-response study Psycho-Oncology, 22(7),
1517-1527. doi: 10.1002/pon.3163
Crumley, J. J., Stetler, C. A., & Horhota, M. (2014). Examining the relationship between
subjective and objective memory performance in older adults: A meta-analysis.
Psychology and Aging, 29(2), 250-263. doi: 10.1037/a0035908
Curran, P. J., & Bauer, D. J. (2011). The disaggregation of within-person and between-person
effects in longitudinal models of change. Annual Review of Psychology, 62, 583-619. doi:
10.1146/annurev.psych.093008.100356
Curran, S. L., Beacham, A. O., & Andrykowski, M. A. (2004). Ecological momentary
assessment of fatigue following breast cancer treatment. Journal of Behavioral Medicine,
27(5), 425-444. doi: 10.1023/B:JOBM.0000047608.03692.0c
Curt, G. A., Breitbart, W., Cella, D., Groopman, J. E., Horning, S. J., Itri, L. M., . . . Vogelzang,
N. J. (2000). Impact of cancer-related fatigue on the lives of patients: New findings from
the fatigue coalition. The Oncologist, 5(5), 353-360. doi: 10.1634/theoncologist.5-5-353
Damholdt, M. F., Mehlsen, M., O'Toole, M. S., Andreasen, R. K., Pedersen, A. D., Zachariae,
R., . . . Pedersen, A. D. (2016). Web-based cognitive training for breast cancer survivors
with cognitive complaints-a randomized controlled trial. Psycho-Oncology, 25(11), 12931300. doi: 10.1002/pon.4058
Denlinger, C. S., Carlson, R. W., Are, M., Baker, K. S., Davis, E., Edge, S. B., . . . FreedmanCass, D. (2014). Survivorship: Introduction and definition: Clinical practice guidelines in
oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 12(1), 3445.

80

Derry, H. M., Jaremka, L. M., Bennett, J. M., Peng, J., Andridge, R., Shapiro, C., . . . KiecoltGlaser, J. K. (2015). Yoga and self-reported cognitive problems in breast cancer
survivors: A randomized controlled trial. Psycho-Oncology, 24(8), 958-966.
DeSantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., . . . Jemal,
A. (2014). Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for
Clinicians, 64(4), 252-271. doi: 10.3322/caac.21235
Dijk, D. J., Duffy, J. F., & Czeisler, C. A. (1992). Circadian and sleep/wake dependent aspects of
subjective alertness and cognitive performance. Journal of Sleep Research, 1(2), 112117. doi: 10.1111/j.1365-2869.1992.tb00021.x
Donovan, K. A., Small, B. J., Andrykowski, M. A., Schmitt, F. A., Munster, P., & Jacobsen, P.
B. (2005). Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for
early-stage breast carcinoma. Cancer, 104(11), 2499-2507. doi: 10.1002/cncr.21482
Fahrenberg, J., Myrtek, M., Pawlik, K., & Perrez, M. (2007). Ambulatory assessment Monitoring behavior in daily life settings. European Journal of Psychological
Assessment, 23(4), 206-213. doi: doi:10.1027/1015-5759.23.4.206
Fernandes, R., Stone, P., Andrews, P., Morgan, R., & Sharma, S. (2006). Comparison between
fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy
volunteers: Evaluation of diagnostic criteria for cancer-related fatigue. Journal of Pain
and Symptom Management, 32(3), 245-254. doi: 10.1016/j.jpainsymman.2006.03.014
Ganz, P. A., Desmond, K. A., Leedham, B., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R.
(2002). Quality of life in long-term, disease-free survivors of breast cancer: A follow-up
study. Journal of the National Cancer Institute, 94(1), 39-49.

81

Goldstein, D., Bennett, B. K., Webber, K., Boyle, F., de Souza, P. l., Wilcken, N. R. C., . . .
Lloyd, A. R. (2012). Cancer-related fatique in women with breast cancer: Outcomes of a
5-year prospective cohort study. Journal of Clincal Oncology, 30(15), 1805-1812. doi:
10.1200/JCO.2011.34.6148
Gunstad, J., Paul, R. H., Brickman, A. M., Cohen, R. A., Arns, M., Roe, D., . . . Gordon, E.
(2006). Patterns of cognitive performance in middle-aged and older adults: A cluster
analytic examination. Journal of Geriatric Psychiatry and Neurology, 19(2), 59-64. doi:
10.1177/0891988705284738
Hann, D. M., Jacobsen, P. B., Azzarello, L. M., Martin, S. C., Curran, S. L., Fields, K. K., . . .
Lyman, G. (1998). Measurement of fatigue in cancer patients: Development and
validation of the Fatigue Symptom Inventory. Quality of Life Research, 7(4), 301-310.
doi: 10.1023/A:1024929829627
Hayes, A. F. (2006). A primer on multilevel modeling. Human Communication Research, 32,
385-410. doi: 10.1111/j.1468-2958.2006.00281.x
Heron, K. E., & Smyth, J. M. (2010). Ecological momentary interventions: Incorporating mobile
technology into psychosocial and health behaviour treatments. British Journal of Health
Psychology, 15(1), 1-39. doi: 10.1348/135910709X466063
Hewitt, M. E., Greenfield, S., Stovall, E., & Board, N. C. P. (Eds.). (2006). From cancer patient
to cancer survivor: Lost in transition. Washington, D.C.: National Academies Press.
Hill, N. L., Mogle, J. M., Munoz, E., Wion, R., & Colancecco, E. M. (2015). Assessment of
subjective cognitive impairment among older adults. Journal of Gerontological Nursing,
41(4), 28-35. doi: 10.3928/00989134-20150309-01

82

Hoffman, L. (2015). Longitudinal analysis: Modeling within-person fluctuation and change.
New York, NY, US: Routledge/Taylor & Francis Group.
Hoffman, L., & Stawski, R. S. (2009). Persons as contexts: Evaluating between-person and
within-person effects in longitudinal analysis. Research in Human Development, 6(2-3),
97-120. doi: 10.1080/15427600902911189
Hofman, M., Ryan, J. L., Figueroa-Moseley, C. D., Jean-Pierre, P., & Morrow, G. R. (2007).
Cancer-related fatigue: The scale of the problem. The Oncologist, 12(suppl 1), 4-10. doi:
10.1634/theoncologist.12-S1-4
Hox, J. J. (2010). Multilevel Analysis: Techniques and Applications (Second ed.). New York,
NY: Routledge.
Hsu, T., Ennis, M., Hood, N., Graham, M., & Goodwin, P. J. (2013). Quality of life in long-term
breast cancer survivors. Journal of Clincal Oncology, 31(28), 3540-3548. doi:
10.1200/JCO.2012.48.1903
Hulur, G., Hertzog, C., Pearman, A., Ram, N., & Gerstorf, D. (2014). Longitudinal associations
of subjective memory with memory performance and depressive symptoms: Betweenperson and within-person perspectives. Psychology and Aging, 29(4), 814-827. doi:
10.1037/a0037619
Hulur, G., Hertzog, C., Pearman, A. M., & Gerstorf, D. (2015). Correlates and moderators of
change in subjective memory and memory performance: Findings from the health and
retirement study. Gerontology, 61(3), 232-240. doi: 10.1159/000369010

83

Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012).
Complications of treatment: Objective and subjective cognitive impairment following
chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38, 926-934.
doi: 10.1016/j.ctrv.2012.05.002
Jacobsen, P. B., Donovan, K. A., Vadaparampil, S. T., & Small, B. J. (2007). Systematic review
and meta-analysis of psychological and activity-based interventions for cancer-related
fatigue. Health Psychology, 26(6), 660-667. doi: 10.1037/0278-6133.26.6.660
Janelsins, M. C., Heckler, C. E., Peppone, L. J., Kamen, C., Mustian, K. M., Mohile, S. G., . . .
Morrow, G. R. (2017). Cognitive complaints in survivors of breast cancer after
chemotherapy compared with age-matched controls: An analysis from a nationwide,
multicenter, prospective longitudinal study. Journal of Clinical Oncology, 35(5), 506514. doi: 10.1200/jco.2016.68.5826
Jim, H. S., Donovan, K. A., Small, B. J., Andrykowski, M. A., Munster, P. N., & Jacobsen, P. B.
(2009). Cognitive functioning in breast cancer survivors: A controlled comparison.
Cancer, 115(8), 1776-1783. doi: 10.1002/cncr.24192
Jim, H. S., Phillips, K. M., Chait, S., Faul, L. A., Popa, M. A., Lee, Y. H., . . . Small, B. J.
(2012). Meta-analysis of cognitive functioning in breast cancer survivors previously
treated with standard-dose chemotherapy. Journal of Clinical Oncology, 30(29), 35783587. doi: 10.1200/jco.2011.39.5640
Jones, J. M., Olson, K., Catton, P., Catton, C. N., Fleshner, N. E., Krzyzanowska, M. K., . . .
Howell, D. (2016). Cancer-related fatigue and associated disability in post-treatment
cancer survivors. Journal of Cancer Survivorship, 10(1), 51-61. doi: 10.1007/s11764015-0450-2

84

Kim, J., Kikuchi, H., & Yamamoto, Y. (2013). Systematic comparison between ecological
momentary assessment and day reconstruction method for fatigue and mood states in
healthy adults. British Journal of Health Psychology, 18(1), 155-167. doi:
10.1111/bjhp.12000
Klemp, J. R., Myers, J. S., Fabian, C. J., Kimler, B. F., Khan, Q. J., Sereika, S. M., & Stanton, A.
L. (2018). Cognitive functioning and quality of life following chemotherapy in pre- and
peri-menopausal women with breast cancer. Supportive Care in Cancer, 26(2), 575-583.
doi: 10.1007/s00520-017-3869-3
Kreukels, B. P. C., van Dam, F. S. A. M., Ridderinkhof, K. R., Boogerd, W., & Schagen, S.
(2008). Original Contribution: Persistent neurocognitive problems after adjuvant
chemotherapy for breast cancer. Clinical Breast Cancer, 8, 80-87. doi:
10.3816/CBC.2008.n.006
Mandelblatt, J. S., Hurria, A., McDonald, B. C., Saykin, A. J., Stern, R. A., VanMeter, J. W., . . .
Ahles, T. (2013). Cognitive effects of cancer and its treatments at the intersection of
aging: What do we know; what do we need to know? Seminars in Oncology, 40(6), 709725. doi: 10.1053/j.seminoncol.2013.09.006
Mandelblatt, J. S., Stern, R. A., Luta, G., McGuckin, M., Clapp, J. D., Hurria, A., . . . Ahles, T.
(2014). Cognitive impairment in older patients with breast cancer before systemic
therapy: Is there an interaction between cancer and comorbidity? Journal of Clincal
Oncology, 32(18), 1909-1918. doi: 10.1200/JCO.2013.54.2050
Mansell, J. (1985). Time sampling and measurement error: The effect of interval length and
sampling pattern. Journal of Behavior Therapy and Experimental Psychiatry, 16(3), 245251.

85

Mehnert, A., Scherwath, A., Schirmer, L., Schleimer, B., Petersen, C., Schulz-Kindermann, F., . .
. Koch, U. (2007). The association between neuropsychological impairment, selfperceived cognitive deficits, fatigue and health related quality of life in breast cancer
survivors following standard adjuvant versus high-dose chemotherapy. Patient Education
and Counseling, 66, 108-118. doi: 10.1016/j.pec.2006.11.005
Miller, G. (2012). The smartphone psychology manifesto. Perspectives on Psychological
Science, 7(3), 221-237. doi: 10.1177/1745691612441215
Minton, O., Berger, A., Barsevick, A., Cramp, F., Goedendorp, M., Mitchell, S. A., & Stone, P.
C. (2013). Cancer-related fatigue and its impact on functioning. Cancer, 119, 2124-2130.
doi: 10.1002/cncr.28058
Minton, O., & Stone, P. (2009). A systematic review of the scales used for the measurement of
cancer-related fatigue (CRF). Annals of Oncology, 20(1), 17-25. doi:
10.1093/annonc/mdn537
Mock, V., Atkinson, A., Barsevick, A., Cella, D., Cimprich, B., Cleeland, C., . . . National
Comprehensive Cancer, N. (2000). NCCN practice guidelines for cancer-related fatigue.
Oncology (Williston Park, N.Y.), 14(11A), 151-161.
Mogle, J. M. (2011). Development of a daily diary method for the assessment of everyday
cognitive failures. Syracuse University. Retrieved from http://surface.syr.edu/psy_etd/160
(Paper 160)
Mogle, J. M., Munoz, E., Hill, N. L., Smyth, J. M., & Sliwinski, M. J. (2017). Daily Memory
Lapses in Adults: Characterization and Influence on Affect. Journals of Gerontology
Series B: Psychological Sciences and Social Sciences. doi: 10.1093/geronb/gbx012

86

Mormont, M. C., Waterhouse, J., Bleuzen, P., Giacchetti, S., Jami, A., Bogdan, A., . . . Levi, F.
(2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better
response, and longer survival in patients with metastatic colorectal cancer and good
performance status. Clinical Cancer Research, 6(8), 3038-3045.
Moskowitz, D. S., Russell, J. J., Sadikaj, G., & Sutton, R. (2009). Measuring people intensively.
Canadian Psychology/Psychologie canadienne, 50(3), 131-140. doi: 10.1037/a0016625
Moskowitz, D. S., & Young, S. N. (2006). Ecological momentary assessment: What it is and
why it is a method of the future in clinical psychopharmacology. Journal of Psychiatry
and Neuroscience, 31(1), 13-20.
Myers, J. S., Wick, J. A., & Klemp, J. R. (2015). Potential factors associated with perceived
cognitive impairment in breast cancer survivors. Supportive Care in Cancer, 23(11),
3219-3228. doi: 10.1007/s00520-015-2708-7
Ono, M., Ogilvie, J. M., Wilson, J. S., Green, H. J., Chambers, S. K., Ownsworth, T., & Shum,
D. H. K. (2015). A meta-analysis of cognitive impairment and decline associated with
adjuvant chemotherapy in women with breast cancer. Frontiers in Oncology, 5, 59. doi:
10.3389/fonc.2015.00059
Parisi, J. M., Gross, A. L., Rebok, G. W., Saczynski, J. S., Crowe, M., Cook, S. E., . . .
Unverzagt, F. W. (2011). Modeling change in memory performance and memory
perceptions: Findings from the ACTIVE study. Psychology and Aging, 26(3), 518-524.
doi: 10.1037/a0022458
Pearman, A., Hertzog, C., & Gerstorf, D. (2014). Little evidence for links between memory
complaints and memory performance in very old age: Longitudinal analyses from the
Berlin Aging Study. Psychology and Aging, 29(4), 828-842. doi: 10.1037/a0037141

87

Phillips, K. M., Jim, H. S., Small, B. J., Laronga, C., Andrykowski, M. A., & Jacobsen, P. B.
(2012). Cognitive functioning after cancer treatment: A 3-year longitudinal comparison
of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.
Cancer, 118(7), 1925-1932. doi: 10.1002/cncr.26432
Phillips, S. M., Lloyd, G. R., Awick, E. A., & McAuley, E. (2017). Relationship between selfreported and objectively measured physical activity and subjective memory impairment
in breast cancer survivors: Role of self-efficacy, fatigue and distress. Psycho-Oncology,
26(9), 1390-1399. doi: 10.1002/pon.4156
Pinto, A. C., & de Azambuja, E. (2011). Improving quality of life after breast cancer: Dealing
with symptoms. Maturitas, 70(4), 343-348. doi: 10.1016/j.maturitas.2011.09.008
Piper, B. F., & Cella, D. (2010). Cancer-related fatigue: Definitions and clinical subtypes.
Journal of the National Comprehensive Cancer Network : JNCCN, 8(8), 958-966.
Poppelreuter, M., Weis, J., Külz, A. K., Tucha, O., Lange, K. W., & Bartsch, H. H. (2004).
Cognitive dysfunction and subjective complaints of cancer patients: A cross-sectional
study in a cancer rehabilitation centre. European Journal of Cancer, 40, 43-49. doi:
10.1016/j.ejca.2003.08.001
Pullens, M. J. J., De Vries, J., & Roukema, J. A. (2010). Subjective cognitive dysfunction in
breast cancer patients: A systematic review. Psycho-Oncology, 19(11), 1127-1138. doi:
10.1002/pon.1673
Rabin, L. A., Smart, C. M., Crane, P. K., Amariglio, R. E., Berman, L. M., Boada, M., . . .
Sikkes, S. A. (2015). Subjective cognitive decline in older adults: An overview of selfreport measures used across 19 international research studies. Journal of Alzheimers
Disease, 48 Suppl 1, S63-S86. doi: 10.3233/jad-150154

88

Radloff, L. S. (1977). The CES-D Scale. Applied Psychological Measurement, 1(3), 385-401.
doi: doi:10.1177/014662167700100306
Rey, D., Bouhnik, A., Mancini, J., Bendiane, M., Séror, V., & Viens, P. (2012). Self-reported
cognitive impairment after breast cancer treatment in young women from the ELIPPSE40
cohort: The long-term impact of chemotherapy. Breast Journal, 18(5), 406-414. doi:
10.1111/j.1524-4741.2012.01275.x
Ribi, K., Aldridge, J., Phillips, K. A., Thompson, A., Harvey, V., Thurlimann, B., . . . Bernhard,
J. (2012). Subjective cognitive complaints one year after ceasing adjuvant endocrine
treatment for early-stage breast cancer. British Journal of Cancer, 106(10), 1618-1625.
doi: 10.1038/bjc.2012.156
Rock, C. L., Doyle, C., Demark-Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A.
L., . . . Gansler, T. (2012). Nutrition and physical activity guidelines for cancer survivors.
CA: A Cancer Journal for Clinicians, 62(4), 242-274. doi: 10.3322/caac.21142
Rowland, J. H., & Bellizzi, K. M. (2014). Cancer survivorship issues: Life after treatment and
implications for an aging population. Journal of Clinical Oncology, 32(24), 2662-2668.
doi: 10.1200/JCO.2014.55.8361
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R.
L., . . . Ganz, P. A. (2015). American Cancer Society/American Society of Clinical
Oncology Breast Cancer Survivorship Care Guideline. Journal of Clinical Oncology. doi:
10.1200/jco.2015.64.3809

89

Runyan, J. D., Steenbergh, T. A., Bainbridge, C., Daugherty, D. A., Oke, L., & Fry, B. N.
(2013). A smartphone ecological momentary assessment/intervention "app" for collecting
real-time data and promoting self-awareness. PLoS One, 8(8), e71325. doi:
10.1371/journal.pone.0071325
Runyan, J. D., & Steinke, E. G. (2015). Virtues, ecological momentary assessment/intervention
and smartphone technology. Frontiers in Psychology, 6, 481. doi:
10.3389/fpsyg.2015.00481
Schagen, S. B., Das, E., & Vermeulen, I. (2012). Information about chemotherapy-associated
cognitive problems contributes to cognitive problems in cancer patients. PsychoOncology, 21(10), 1132-1135. doi: 10.1002/pon.2011
Schmidt, C., Collette, F., Cajochen, C., & Peigneux, P. (2007). A time to think: Circadian
rhythms in human cognition. Cognitive Neuropsychology, 24(7), 755-789. doi:
10.1080/02643290701754158
Schmidt, M. E., Chang‐Claude, J., Seibold, P., Vrieling, A., Heinz, J., Flesch‐Janys, D., &
Steindorf, K. (2015). Determinants of long‐term fatigue in breast cancer survivors:
Results of a prospective patient cohort study. Psycho‐Oncology, 24(1), 40-46. doi:
10.1002/pon.3581
Schwartz, A. L. (2000). Daily fatigue patterns and effect of exercise in women with breast
cancer. Cancer Practice, 8(1), 16-24.
Schwartz, A. L., Mori, M., Gao, R., Nail, L. M., & King, M. E. (2001). Exercise reduces daily
fatigue in women with breast cancer receiving chemotherapy. Medicine and Science in
Sports and Exercise, 33(5), 718-723.

90

Scott, S. B., Graham-Engeland, J. E., Engeland, C. G., Smyth, J. M., Almeida, D. M., Katz, M.
J., . . . Sliwinski, M. J. (2015). The effects of stress on cognitive aging, physiology and
emotion (ESCAPE) project. BMC Psychiatry, 15. doi: 10.1186/s12888-015-0497-7
Servaes, P., Gielissen, M. F. M., Verhagen, S., & Bleijenberg, G. (2007). The course of severe
fatigue in disease-free breast cancer patients: A longitudinal study. Psycho-Oncology,
16(9), 787-795. doi: 10.1002/pon.1120
Servaes, P., Verhagen, C., & Bleijenberg, G. (2002). Fatigue in cancer patients during and after
treatment: Prevalence, correlates and interventions. European Journal of Cancer, 38(1),
27-43.
Shiffman, S., Stone, A. A., & Hufford, M. R. (2008). Ecological momentary assessment. Annual
Review of Clinical Psychology, 4, 1-32.
Shilling, V., & Jenkins, V. (2007). Self-reported cognitive problems in women receiving
adjuvant therapy for breast cancer. European Journal of Oncology Nursing(1), 6-15. doi:
10.1016/j.ejon.2006.02.005
Singer, J. D., & Willett, J. B. (2003). Applied longitudinal data analysis: Modeling change and
event occurrence. New York, NY, US: Oxford University Press.
Sliwinski, M. J. (2008). Measurement-burst designs for social health research. Social and
Personality Psychology Compass, 2(1), 245-261. doi: 10.1111/j.1751-9004.2007.00043.x
Small, B. J., Scott, S. B., Jim, H. S., & Jacobsen, P. B. (2015). Is cancer a risk factor for
cognitive decline in late life? Gerontology, 61(6), 561-566. doi: 10.1159/000381022
Society, A. C. (2015). Cancer Facts & Figures 2015. Atlanta: American Cancer Society.

91

Stone, A. A., & Shiffman, S. (2002). Capturing momentary, self-report data: A proposal for
reporting guidelines. Annals of Behavioral Medicine, 24(3), 236-243. doi:
10.1207/s15324796abm2403_09
Stone, P. C., & Minton, O. (2008). Cancer-related fatigue. European Journal of Cancer, 44(8),
1097-1104. doi: 10.1016/j.ejca.2008.02.037
Stone, P. C., Richardson, A., Ream, E., Smith, A. G., Kerr, D. J., & Kearney, N. (2000). Cancerrelated fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient
survey. Cancer Fatigue Forum. Annals of Oncology, 11(8), 971-975.
Sunderland, A., Harris, J. E., & Baddeley, A. D. (1983). Do laboratory tests predict everyday
memory? A neuropsychological study. Journal of Verbal Learning & Verbal Behavior,
22, 341-357. doi: 10.1016/S0022-5371(83)90229-3
Timmerman, J. G., Weering, M. G. H. D.-v., Tönis, T. M., Hermens, H. J., & VollenbroekHutten, M. M. R. (2015). Relationship between patterns of daily physical activity and
fatigue in cancer survivors. European Journal of Oncology Nursing, 19(2), 162-168. doi:
https://doi.org/10.1016/j.ejon.2014.09.005
Trull, T. J., & Ebner-Priemer, U. (2013). Ambulatory assessment. Annual Review of Clinical
Psychology, 9, 151-176. doi: 10.1146/annurev-clinpsy-050212-185510
Valdez, P., Ramirez, C., & Garcia, A. (2012). Circadian rhythms in cognitive performance:
Implications for neuropsychological assessment. ChronoPhysiology and Therapy, 81-92.
doi: 10.2147/CPT.S32586

92

Von Ah, D., & Tallman, E. F. (2015). Perceived cognitive function in breast cancer survivors:
Evaluating relationships with objective cognitive performance and other symptoms using
the Functional Assessment of Cancer Therapy—cognitive Function Instrument. Journal
of Pain and Symptom Management, 49(4), 697-706. doi:
https://doi.org/10.1016/j.jpainsymman.2014.08.012
Walls, T. A., & Schafer, J. L. (2006). Models for intensive longitudinal data. Oxford: Oxford
University Press.
Wang, L. P., & Maxwell, S. E. (2015). On disaggregating between-person and within-person
effects with longitudinal data using multilevel models. Psychological Methods, 20(1), 6383. doi: 10.1037/met0000030
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015). Clinical characteristics,
pathophysiology, and management of noncentral nervous system cancer-related cognitive
impairment in adults. CA: A Cancer Journal for Clinicians, 65(2), 123-138. doi:
10.3322/caac.21258
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004).
‘Chemobrain’ in breast carcinoma? Cancer, 101(3), 466-475. doi: 10.1002/cncr.20393
Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late onset
cognitive dysfunction associated with chemotherapy in women with breast cancer.
Cancer, 116(14), 3348-3349. doi: 10.1002/cncr.25098
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011). International Cognition and Cancer
Task Force recommendations to harmonise studies of cognitive function in patients with
cancer. Lancet Oncology, 12(7), 703-708. doi: 10.1016/S1470-2045(10)70294-1

93

Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997). Measuring fatigue
and other anemia-related symptoms with the Functional Assessment of Cancer Therapy
(FACT) measurement system. Journal of Pain and Symptom Management, 13(2), 63-74.
doi: https://doi.org/10.1016/S0885-3924(96)00274-6

94

Appendix A:
IRB Approval Letter

2/1/2018
Brent Small, Ph.D.
School of Aging
Studies
4202 E Fowler Ave., MHC1300
Tampa, FL 33620
RE:
IRB#:
Title:

Expedited Approval for Continuing Review
CR3_Pro00015048
Daily Cognitive Functioning Among Cancer Survivors

Study Approval Period: 2/27/2018 to 2/27/2019
Dear Dr. Small:
On 1/31/2018, the Institutional Review Board (IRB) reviewed and APPROVED the above
application and all documents contained within including those outlined below.

Approved
Item(s): Protocol
Document(s):
2016.06.23 V10 Moffitt protocol_clean.docx
The IRB determined that your study qualified for expedited review based on federal
expedited category number(s):
95

(7) Research on individual or group characteristics or behavior (including, but not limited
to, research on perception, cognition, motivation, identity, language, communication,
cultural beliefs or practices, and social behavior) or research employing survey, interview,
oral history, focus group, program evaluation, human factors evaluation, or quality
assurance methodologies.
As the principal investigator of this study, it is your responsibility to conduct this study
in accordance with USF HRPP policies and procedures and as approved by the USF
IRB. Any changes to the approved research must be submitted to the IRB for review
and approval by an amendment. Additionally, all unanticipated problems must be
reported to the USF IRB within five (5) calendar days.

We appreciate your dedication to the ethical conduct of human subject research at the
University of South Florida and your continued commitment to human research protections.
If you have any questions regarding this matter, please call 813-974-5638.
Sincerely,

Kristen Salomon, Ph.D., Vice
Chairperson USF Institutional Review
Board

96

